Gene Symbol | Gene ID | Gene Info |
---|---|---|
Zbtb18
|
ENSMUSG00000063659.6 | zinc finger and BTB domain containing 18 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr1_177449970_177450141 | Zbtb18 | 4234 | 0.176238 | -0.61 | 9.0e-07 | Click! |
chr1_177448201_177448585 | Zbtb18 | 2572 | 0.222652 | -0.59 | 1.7e-06 | Click! |
chr1_177444261_177444423 | Zbtb18 | 47 | 0.950999 | -0.58 | 3.7e-06 | Click! |
chr1_177447914_177448167 | Zbtb18 | 2219 | 0.245329 | -0.56 | 7.6e-06 | Click! |
chr1_177444528_177444714 | Zbtb18 | 28 | 0.960270 | -0.56 | 9.8e-06 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr8_25343429_25343737 | 55.18 |
5430421F17Rik |
RIKEN cDNA 5430421F17 gene |
37313 |
0.12 |
chr5_134895375_134895572 | 54.80 |
Tmem270 |
transmembrane protein 270 |
11260 |
0.09 |
chr19_56177181_56177795 | 51.63 |
Gm31912 |
predicted gene, 31912 |
71178 |
0.1 |
chr2_174347204_174348264 | 50.76 |
Gm20721 |
predicted gene, 20721 |
1022 |
0.44 |
chr4_139179928_139180623 | 48.99 |
Gm16287 |
predicted gene 16287 |
380 |
0.82 |
chr5_137349031_137350198 | 45.22 |
Ephb4 |
Eph receptor B4 |
495 |
0.62 |
chr17_25083410_25083921 | 42.90 |
Tmem204 |
transmembrane protein 204 |
74 |
0.95 |
chr6_72248461_72248628 | 42.29 |
Atoh8 |
atonal bHLH transcription factor 8 |
12967 |
0.15 |
chr3_152549002_152549525 | 41.40 |
Ak5 |
adenylate kinase 5 |
22511 |
0.2 |
chr14_54443728_54443932 | 40.77 |
5430430K15Rik |
RIKEN cDNA 5430430K15 gene |
2488 |
0.12 |
chr19_14180233_14180400 | 40.62 |
Gm26993 |
predicted gene, 26993 |
161945 |
0.03 |
chr4_150809363_150809664 | 39.76 |
Gm13049 |
predicted gene 13049 |
16220 |
0.16 |
chr4_126150288_126150988 | 39.36 |
Eva1b |
eva-1 homolog B (C. elegans) |
2106 |
0.18 |
chr6_83137634_83138375 | 38.72 |
Rtkn |
rhotekin |
894 |
0.27 |
chr8_83739432_83739624 | 38.62 |
Adgre5 |
adhesion G protein-coupled receptor E5 |
1641 |
0.25 |
chr2_32317120_32318698 | 37.83 |
Gm23363 |
predicted gene, 23363 |
356 |
0.45 |
chr2_62573777_62574179 | 37.30 |
Fap |
fibroblast activation protein |
2 |
0.98 |
chr17_12801980_12802361 | 35.56 |
Gm49958 |
predicted gene, 49958 |
1375 |
0.25 |
chr12_79674954_79675872 | 34.51 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
249320 |
0.02 |
chr3_57604667_57604844 | 32.61 |
Mir6377 |
microRNA 6377 |
11854 |
0.12 |
chr8_70611040_70612208 | 32.39 |
Gm45546 |
predicted gene 45546 |
1199 |
0.25 |
chr1_16248955_16249422 | 32.22 |
Gm7568 |
predicted gene 7568 |
4404 |
0.22 |
chr14_14351950_14353283 | 31.97 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr17_26530762_26530927 | 31.66 |
Gm50274 |
predicted gene, 50274 |
5551 |
0.11 |
chr2_164452410_164452561 | 31.40 |
Sys1 |
SYS1 Golgi-localized integral membrane protein homolog (S. cerevisiae) |
4479 |
0.09 |
chr5_64575874_64576255 | 30.91 |
Gm42566 |
predicted gene 42566 |
11245 |
0.12 |
chr8_93180539_93180878 | 30.75 |
Ces1d |
carboxylesterase 1D |
5419 |
0.15 |
chr2_131401817_131402196 | 30.61 |
Gm22902 |
predicted gene, 22902 |
11956 |
0.14 |
chr6_4484046_4484465 | 30.53 |
Gm37883 |
predicted gene, 37883 |
57 |
0.97 |
chr11_99056016_99056446 | 30.18 |
Igfbp4 |
insulin-like growth factor binding protein 4 |
8920 |
0.12 |
chr4_141667950_141668101 | 30.15 |
Plekhm2 |
pleckstrin homology domain containing, family M (with RUN domain) member 2 |
3126 |
0.17 |
chr1_57905961_57906300 | 29.78 |
Spats2l |
spermatogenesis associated, serine-rich 2-like |
4059 |
0.23 |
chr10_80081115_80081433 | 29.29 |
Sbno2 |
strawberry notch 2 |
5835 |
0.1 |
chr17_46086573_46086762 | 29.13 |
Gm36200 |
predicted gene, 36200 |
2401 |
0.2 |
chr4_14273616_14273932 | 28.84 |
Gm24908 |
predicted gene, 24908 |
34156 |
0.18 |
chr16_26041382_26041987 | 28.77 |
AU015336 |
expressed sequence AU015336 |
416 |
0.88 |
chr2_50789120_50789322 | 27.72 |
Gm13498 |
predicted gene 13498 |
120463 |
0.06 |
chr1_135731863_135732606 | 27.69 |
Csrp1 |
cysteine and glycine-rich protein 1 |
3087 |
0.22 |
chr14_69421207_69421358 | 27.45 |
Gm16867 |
predicted gene, 16867 |
5195 |
0.14 |
chr13_9695884_9696115 | 27.41 |
Zmynd11 |
zinc finger, MYND domain containing 11 |
140 |
0.95 |
chr18_78267295_78267780 | 27.28 |
Slc14a2 |
solute carrier family 14 (urea transporter), member 2 |
58443 |
0.14 |
chr14_102859651_102859809 | 26.71 |
Gm34589 |
predicted gene, 34589 |
24972 |
0.2 |
chr7_108797627_108797969 | 26.68 |
Gm45232 |
predicted gene 45232 |
2795 |
0.17 |
chr15_83223251_83223918 | 26.20 |
A4galt |
alpha 1,4-galactosyltransferase |
28145 |
0.1 |
chr18_60674188_60674688 | 26.00 |
Synpo |
synaptopodin |
14296 |
0.16 |
chr10_23059988_23060342 | 25.96 |
Eya4 |
EYA transcriptional coactivator and phosphatase 4 |
55031 |
0.14 |
chr14_68934600_68935507 | 25.89 |
Gm47256 |
predicted gene, 47256 |
60218 |
0.12 |
chr11_117265661_117266789 | 25.42 |
Septin9 |
septin 9 |
21 |
0.97 |
chr10_61308905_61309056 | 25.37 |
Rpl27a-ps1 |
ribosomal protein L27A, pseudogene 1 |
850 |
0.51 |
chr1_162217277_162218166 | 25.33 |
Dnm3os |
dynamin 3, opposite strand |
2 |
0.57 |
chr13_47765042_47765205 | 25.28 |
4930471G24Rik |
RIKEN cDNA 4930471G24 gene |
97573 |
0.08 |
chr2_73495948_73496167 | 25.04 |
Wipf1 |
WAS/WASL interacting protein family, member 1 |
9588 |
0.17 |
chr15_103371320_103371471 | 25.00 |
Itga5 |
integrin alpha 5 (fibronectin receptor alpha) |
4632 |
0.13 |
chr13_102625177_102625520 | 24.52 |
Gm47014 |
predicted gene, 47014 |
20815 |
0.2 |
chr13_95745685_95745843 | 24.43 |
Gm32880 |
predicted gene, 32880 |
9181 |
0.16 |
chr2_152705940_152706549 | 24.23 |
H13 |
histocompatibility 13 |
14405 |
0.1 |
chr9_20971774_20972514 | 24.21 |
S1pr2 |
sphingosine-1-phosphate receptor 2 |
1834 |
0.17 |
chr6_87152703_87152854 | 24.13 |
Gm44415 |
predicted gene, 44415 |
11926 |
0.15 |
chr7_107567042_107567677 | 23.67 |
Olfml1 |
olfactomedin-like 1 |
87 |
0.96 |
chr13_48566607_48566899 | 23.62 |
Gm25232 |
predicted gene, 25232 |
5631 |
0.1 |
chr6_135333919_135334257 | 23.58 |
Gm44275 |
predicted gene, 44275 |
14527 |
0.12 |
chr10_127609489_127609694 | 23.06 |
Lrp1 |
low density lipoprotein receptor-related protein 1 |
11331 |
0.09 |
chr7_72215902_72216107 | 22.95 |
Mctp2 |
multiple C2 domains, transmembrane 2 |
13356 |
0.25 |
chr9_117091402_117091553 | 22.88 |
Gm20397 |
predicted gene 20397 |
25950 |
0.21 |
chr8_115929769_115930140 | 22.84 |
Gm45733 |
predicted gene 45733 |
42117 |
0.21 |
chr8_20379727_20380988 | 22.84 |
Gm7807 |
predicted gene 7807 |
724 |
0.67 |
chr10_77116511_77116903 | 22.79 |
Col18a1 |
collagen, type XVIII, alpha 1 |
2761 |
0.25 |
chr9_104582673_104583033 | 22.79 |
Cpne4 |
copine IV |
2485 |
0.39 |
chr17_4200006_4200164 | 22.77 |
4930548J01Rik |
RIKEN cDNA 4930548J01 gene |
77972 |
0.11 |
chr9_43252901_43253063 | 22.70 |
D630033O11Rik |
RIKEN cDNA D630033O11 gene |
6898 |
0.16 |
chr5_102671119_102671281 | 22.66 |
Arhgap24 |
Rho GTPase activating protein 24 |
53773 |
0.17 |
chr3_121588840_121589464 | 22.57 |
A730020M07Rik |
RIKEN cDNA A730020M07 gene |
54215 |
0.09 |
chr4_149871019_149871336 | 22.53 |
Gm13070 |
predicted gene 13070 |
32829 |
0.1 |
chr15_94238011_94238507 | 22.39 |
Adamts20 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 20 |
165999 |
0.04 |
chr11_50622310_50622834 | 22.28 |
Gm12198 |
predicted gene 12198 |
20124 |
0.17 |
chr5_120097186_120097337 | 22.23 |
Rbm19 |
RNA binding motif protein 19 |
19204 |
0.18 |
chr2_7246002_7246183 | 22.20 |
Gm24340 |
predicted gene, 24340 |
104005 |
0.08 |
chr9_20987021_20987266 | 22.17 |
S1pr2 |
sphingosine-1-phosphate receptor 2 |
10362 |
0.08 |
chr10_62044569_62044720 | 22.16 |
Gm47919 |
predicted gene, 47919 |
21240 |
0.15 |
chr8_90862006_90862536 | 21.94 |
Gm45641 |
predicted gene 45641 |
12425 |
0.12 |
chr7_103910571_103910996 | 21.91 |
Olfr65 |
olfactory receptor 65 |
4441 |
0.07 |
chr2_138040379_138040668 | 21.86 |
Gm14062 |
predicted gene 14062 |
163692 |
0.04 |
chr2_75000377_75000554 | 21.82 |
n-R5s198 |
nuclear encoded rRNA 5S 198 |
64951 |
0.09 |
chr1_45311391_45311727 | 21.80 |
Col3a1 |
collagen, type III, alpha 1 |
21 |
0.6 |
chr2_50943300_50943451 | 21.71 |
Gm13498 |
predicted gene 13498 |
33691 |
0.23 |
chr7_51969421_51969827 | 21.68 |
Gas2 |
growth arrest specific 2 |
25940 |
0.15 |
chr15_76114317_76114570 | 21.67 |
Eppk1 |
epiplakin 1 |
5752 |
0.08 |
chr2_160932461_160932612 | 21.59 |
Gm14228 |
predicted gene 14228 |
5888 |
0.15 |
chr5_119811188_119811362 | 21.58 |
1700021F13Rik |
RIKEN cDNA 1700021F13 gene |
3406 |
0.22 |
chr6_128208906_128209057 | 21.47 |
Gm19065 |
predicted gene, 19065 |
63 |
0.94 |
chr10_125785483_125786054 | 21.42 |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
180400 |
0.03 |
chr5_136869563_136869747 | 21.38 |
Gm20485 |
predicted gene 20485 |
67 |
0.96 |
chr5_73468882_73469058 | 21.28 |
Gm15653 |
predicted gene 15653 |
8383 |
0.14 |
chr7_16890845_16891287 | 21.14 |
2700080J24Rik |
RIKEN cDNA 2700080J24 gene |
1 |
0.91 |
chr12_8798549_8798996 | 21.13 |
Sdc1 |
syndecan 1 |
26969 |
0.15 |
chr5_29826796_29827181 | 21.06 |
Gm1969 |
predicted gene 1969 |
6319 |
0.16 |
chr14_70471212_70471471 | 21.04 |
Phyhip |
phytanoyl-CoA hydroxylase interacting protein |
12818 |
0.09 |
chr13_56600284_56600504 | 21.00 |
2010203P06Rik |
RIKEN cDNA 2010203P06 gene |
4857 |
0.2 |
chr7_101393716_101394494 | 20.90 |
Arap1 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
263 |
0.87 |
chr5_122146111_122146357 | 20.89 |
Ccdc63 |
coiled-coil domain containing 63 |
5411 |
0.14 |
chr2_173352394_173352793 | 20.85 |
Gm14642 |
predicted gene 14642 |
41973 |
0.15 |
chr2_180303470_180303946 | 20.80 |
Rbbp8nl |
RBBP8 N-terminal like |
13829 |
0.11 |
chr7_140955920_140956826 | 20.68 |
Ifitm2 |
interferon induced transmembrane protein 2 |
386 |
0.43 |
chr18_78473965_78474116 | 20.63 |
4931439C15Rik |
RIKEN cDNA 4931439C15 gene |
2838 |
0.35 |
chr10_71008061_71008221 | 20.60 |
Gm48025 |
predicted gene, 48025 |
15101 |
0.18 |
chr5_137610491_137610906 | 20.53 |
Pcolce |
procollagen C-endopeptidase enhancer protein |
4 |
0.92 |
chr6_87746996_87747194 | 20.51 |
Efcc1 |
EF hand and coiled-coil domain containing 1 |
6427 |
0.09 |
chr2_35513998_35514543 | 20.49 |
Gm35202 |
predicted gene, 35202 |
10739 |
0.13 |
chr15_99332834_99333978 | 20.49 |
Fmnl3 |
formin-like 3 |
2321 |
0.16 |
chr7_128321291_128321673 | 20.40 |
Gm6916 |
predicted pseudogene 6916 |
6698 |
0.11 |
chr5_104096156_104096350 | 20.34 |
Gm26703 |
predicted gene, 26703 |
12964 |
0.11 |
chr10_82690601_82690795 | 20.30 |
Glt8d2 |
glycosyltransferase 8 domain containing 2 |
48 |
0.97 |
chr5_24553717_24553868 | 20.29 |
Iqca1l |
IQ motif containing with AAA domain 1 like |
1159 |
0.29 |
chr9_106355974_106356661 | 20.27 |
Dusp7 |
dual specificity phosphatase 7 |
12315 |
0.12 |
chr8_86820735_86821205 | 20.23 |
N4bp1 |
NEDD4 binding protein 1 |
23075 |
0.16 |
chr17_67866540_67867094 | 20.19 |
Arhgap28 |
Rho GTPase activating protein 28 |
6231 |
0.23 |
chr15_83639182_83639342 | 20.19 |
Scube1 |
signal peptide, CUB domain, EGF-like 1 |
21218 |
0.16 |
chr14_45826265_45826416 | 20.11 |
Gm8317 |
predicted gene 8317 |
32206 |
0.15 |
chr19_48545202_48545700 | 20.06 |
Sorcs3 |
sortilin-related VPS10 domain containing receptor 3 |
115491 |
0.07 |
chr2_167249691_167249873 | 20.06 |
Ptgis |
prostaglandin I2 (prostacyclin) synthase |
9178 |
0.15 |
chr11_11878609_11878988 | 20.05 |
Ddc |
dopa decarboxylase |
1831 |
0.32 |
chr15_36661128_36661295 | 19.84 |
Gm10385 |
predicted gene 10385 |
28892 |
0.1 |
chrX_143827344_143827511 | 19.84 |
Capn6 |
calpain 6 |
13 |
0.56 |
chr10_128779498_128779802 | 19.79 |
Rpsa-ps2 |
ribosomal protein SA, pseudogene 2 |
2400 |
0.13 |
chr1_138720808_138721006 | 19.77 |
Gm8790 |
predicted gene 8790 |
31062 |
0.15 |
chr9_64794477_64794818 | 19.75 |
Dennd4a |
DENN/MADD domain containing 4A |
16693 |
0.19 |
chr19_55194614_55194797 | 19.61 |
Mir6715 |
microRNA 6715 |
2027 |
0.27 |
chr9_107981626_107982218 | 19.60 |
Uba7 |
ubiquitin-like modifier activating enzyme 7 |
1032 |
0.19 |
chr2_134215029_134215237 | 19.52 |
Hao1 |
hydroxyacid oxidase 1, liver |
339174 |
0.01 |
chr1_74180094_74180273 | 19.47 |
Cxcr1 |
chemokine (C-X-C motif) receptor 1 |
13052 |
0.11 |
chr2_127907423_127907588 | 19.45 |
Acoxl |
acyl-Coenzyme A oxidase-like |
1553 |
0.4 |
chr10_77441115_77441597 | 19.41 |
Gm35920 |
predicted gene, 35920 |
16561 |
0.15 |
chr7_134289669_134289922 | 19.36 |
D7Ertd443e |
DNA segment, Chr 7, ERATO Doi 443, expressed |
20955 |
0.22 |
chr14_69661259_69661873 | 19.35 |
Gm27177 |
predicted gene 27177 |
16814 |
0.12 |
chr6_126141432_126141808 | 19.28 |
Ntf3 |
neurotrophin 3 |
23340 |
0.25 |
chr6_72655321_72655710 | 19.20 |
Gm38320 |
predicted gene, 38320 |
3195 |
0.12 |
chr12_119390165_119390727 | 19.20 |
Macc1 |
metastasis associated in colon cancer 1 |
71 |
0.98 |
chr16_63287682_63287841 | 19.17 |
Gm33912 |
predicted gene, 33912 |
70319 |
0.13 |
chr9_116847264_116847490 | 19.16 |
Rbms3 |
RNA binding motif, single stranded interacting protein |
24558 |
0.27 |
chr15_101227928_101228517 | 19.12 |
A330009N23Rik |
RIKEN cDNA A330009N23 gene |
3036 |
0.13 |
chr7_135860728_135860885 | 19.11 |
Gm45241 |
predicted gene 45241 |
6358 |
0.17 |
chr8_103409140_103409572 | 19.04 |
1600027J07Rik |
RIKEN cDNA 1600027J07 gene |
61822 |
0.14 |
chr2_168451791_168452030 | 18.93 |
Gm14234 |
predicted gene 14234 |
33336 |
0.18 |
chr13_51259220_51259624 | 18.89 |
Gm29787 |
predicted gene, 29787 |
53311 |
0.1 |
chr14_69442998_69443617 | 18.89 |
Gm16867 |
predicted gene, 16867 |
16830 |
0.11 |
chr17_44432591_44432946 | 18.76 |
Gm49872 |
predicted gene, 49872 |
64865 |
0.13 |
chr6_143499704_143499926 | 18.73 |
Gm23272 |
predicted gene, 23272 |
34418 |
0.18 |
chr6_36890255_36890607 | 18.70 |
1700111E14Rik |
RIKEN cDNA 1700111E14 gene |
46617 |
0.15 |
chr13_97779794_97780130 | 18.67 |
Gm47577 |
predicted gene, 47577 |
10602 |
0.15 |
chr3_86038678_86038849 | 18.66 |
Sh3d19 |
SH3 domain protein D19 |
114 |
0.95 |
chr7_142486657_142487213 | 18.65 |
Lsp1 |
lymphocyte specific 1 |
2082 |
0.18 |
chr7_29453052_29453769 | 18.61 |
Sipa1l3 |
signal-induced proliferation-associated 1 like 3 |
52042 |
0.1 |
chr5_124206499_124207105 | 18.52 |
Pitpnm2 |
phosphatidylinositol transfer protein, membrane-associated 2 |
9616 |
0.11 |
chr2_172867485_172867888 | 18.51 |
Gm22773 |
predicted gene, 22773 |
3345 |
0.3 |
chr11_6481678_6482001 | 18.45 |
Purb |
purine rich element binding protein B |
5922 |
0.08 |
chr4_62755310_62755925 | 18.45 |
Gm11211 |
predicted gene 11211 |
28080 |
0.15 |
chr8_27089454_27089837 | 18.44 |
Adgra2 |
adhesion G protein-coupled receptor A2 |
4047 |
0.14 |
chr3_24630114_24630286 | 18.42 |
Gm24704 |
predicted gene, 24704 |
68126 |
0.14 |
chr18_80485610_80485820 | 18.35 |
Ctdp1 |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase, subunit 1 |
16020 |
0.16 |
chr6_87142375_87142526 | 18.35 |
Gm44415 |
predicted gene, 44415 |
1598 |
0.33 |
chr11_94881938_94882392 | 18.33 |
A430060F13Rik |
RIKEN cDNA A430060F13 gene |
20406 |
0.11 |
chr9_43261471_43261822 | 18.29 |
D630033O11Rik |
RIKEN cDNA D630033O11 gene |
1766 |
0.31 |
chr17_81336476_81336702 | 18.27 |
Gm50044 |
predicted gene, 50044 |
34244 |
0.18 |
chr16_17809524_17810128 | 18.22 |
Scarf2 |
scavenger receptor class F, member 2 |
5017 |
0.1 |
chr9_116649572_116649723 | 18.18 |
Rbms3 |
RNA binding motif, single stranded interacting protein |
173159 |
0.03 |
chr5_21543829_21544063 | 18.18 |
Lrrc17 |
leucine rich repeat containing 17 |
383 |
0.86 |
chr9_102806048_102806219 | 18.17 |
Gm18655 |
predicted gene, 18655 |
14817 |
0.13 |
chr17_83913691_83914083 | 18.17 |
1810073O08Rik |
RIKEN cDNA 1810073O08 gene |
4050 |
0.16 |
chr6_72981242_72981598 | 18.14 |
Gm18402 |
predicted gene, 18402 |
1642 |
0.32 |
chr3_37353957_37354220 | 18.07 |
Fgf2os |
fibroblast growth factor 2, opposite strand |
4348 |
0.11 |
chr7_74112192_74112373 | 18.00 |
Gm45004 |
predicted gene 45004 |
68544 |
0.1 |
chr2_30833701_30833889 | 17.97 |
Prrx2 |
paired related homeobox 2 |
1177 |
0.35 |
chr16_10814971_10815135 | 17.97 |
Gm11172 |
predicted gene 11172 |
2138 |
0.15 |
chr4_109460528_109460711 | 17.92 |
Rnf11 |
ring finger protein 11 |
16056 |
0.16 |
chr17_7654039_7654243 | 17.91 |
Gm49632 |
predicted gene, 49632 |
8813 |
0.23 |
chr7_136406485_136406636 | 17.90 |
Gm36849 |
predicted gene, 36849 |
53196 |
0.14 |
chr3_37128257_37128628 | 17.87 |
Il2 |
interleukin 2 |
2483 |
0.19 |
chr12_25098272_25099055 | 17.86 |
Id2 |
inhibitor of DNA binding 2 |
1523 |
0.35 |
chr7_81726584_81726917 | 17.78 |
Gm18806 |
predicted gene, 18806 |
15595 |
0.11 |
chr1_180913851_180914101 | 17.77 |
Pycr2 |
pyrroline-5-carboxylate reductase family, member 2 |
8061 |
0.1 |
chr7_134290106_134290335 | 17.76 |
D7Ertd443e |
DNA segment, Chr 7, ERATO Doi 443, expressed |
21380 |
0.22 |
chr9_61163761_61164250 | 17.75 |
I730028E13Rik |
RIKEN cDNA I730028E13 gene |
25490 |
0.14 |
chr5_137072107_137072570 | 17.74 |
Serpine1 |
serine (or cysteine) peptidase inhibitor, clade E, member 1 |
70 |
0.95 |
chr7_105777832_105778740 | 17.74 |
Dchs1 |
dachsous cadherin related 1 |
9266 |
0.09 |
chr3_19426107_19426294 | 17.67 |
Dnajc5b |
DnaJ heat shock protein family (Hsp40) member C5 beta |
82395 |
0.09 |
chr8_47851923_47852217 | 17.65 |
Cldn22 |
claudin 22 |
27588 |
0.12 |
chrX_140567765_140568045 | 17.59 |
AL683809.1 |
TSC22 domain family, member 3 (Tsc22d3), pseuodgene |
15694 |
0.17 |
chr5_35609331_35609878 | 17.58 |
Acox3 |
acyl-Coenzyme A oxidase 3, pristanoyl |
495 |
0.75 |
chr2_167603074_167603240 | 17.48 |
Ube2v1 |
ubiquitin-conjugating enzyme E2 variant 1 |
7491 |
0.12 |
chr10_76634661_76634877 | 17.48 |
Col6a2 |
collagen, type VI, alpha 2 |
11139 |
0.15 |
chr7_135237277_135237436 | 17.47 |
Nps |
neuropeptide S |
21347 |
0.18 |
chr16_21152030_21152324 | 17.42 |
Teddm3 |
transmembrane epididymal family member 3 |
1823 |
0.31 |
chr7_98469184_98469371 | 17.37 |
Gucy2d |
guanylate cyclase 2d |
1583 |
0.25 |
chr3_90606271_90606454 | 17.36 |
S100a4 |
S100 calcium binding protein A4 |
1451 |
0.18 |
chr1_192823078_192823550 | 17.36 |
Gm38360 |
predicted gene, 38360 |
2187 |
0.22 |
chr11_79806137_79806418 | 17.36 |
9130204K15Rik |
RIKEN cDNA 9130204K15 gene |
1105 |
0.5 |
chr8_122511564_122511947 | 17.34 |
Gm26497 |
predicted gene, 26497 |
8919 |
0.09 |
chr3_141498365_141498758 | 17.25 |
Unc5c |
unc-5 netrin receptor C |
32890 |
0.19 |
chr5_145635834_145635985 | 17.25 |
Cyp3a63-ps |
cytochrome P450, family 3, subfamily a, member 63, pseudogene |
1916 |
0.29 |
chr9_30522572_30522838 | 17.23 |
Rps2-ps12 |
ribosomal protein S2, pseudogene 12 |
9765 |
0.22 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.0 | 36.2 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
8.9 | 35.4 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
8.7 | 52.3 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
7.8 | 23.3 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
7.7 | 38.6 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
6.8 | 20.5 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
6.6 | 19.7 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
5.5 | 16.4 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
5.5 | 16.4 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
5.2 | 10.4 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
4.9 | 14.7 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
4.9 | 24.5 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
4.9 | 9.7 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
4.8 | 23.8 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
4.4 | 13.3 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
4.3 | 17.4 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
4.3 | 29.9 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
4.2 | 33.9 | GO:0060426 | lung vasculature development(GO:0060426) |
4.2 | 12.7 | GO:0038091 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
4.2 | 4.2 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
4.2 | 16.8 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
4.2 | 12.5 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
4.1 | 16.5 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
4.1 | 16.4 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
4.1 | 20.4 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
4.1 | 16.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
4.0 | 32.2 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
4.0 | 15.9 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
3.9 | 15.7 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
3.9 | 15.7 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
3.8 | 11.4 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
3.7 | 11.2 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
3.7 | 18.5 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
3.6 | 10.9 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
3.6 | 10.7 | GO:0060437 | lung growth(GO:0060437) |
3.5 | 10.4 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
3.4 | 10.3 | GO:0003032 | detection of oxygen(GO:0003032) |
3.4 | 3.4 | GO:1904192 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
3.4 | 13.6 | GO:1903275 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
3.4 | 60.9 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
3.4 | 3.4 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
3.3 | 9.8 | GO:0002432 | granuloma formation(GO:0002432) |
3.3 | 9.8 | GO:0009804 | coumarin metabolic process(GO:0009804) |
3.2 | 15.8 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
3.1 | 9.4 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
3.1 | 9.4 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
3.1 | 12.5 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
3.1 | 9.3 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
3.0 | 9.1 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
3.0 | 9.1 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
3.0 | 12.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
3.0 | 6.0 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
3.0 | 8.9 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
3.0 | 11.9 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
3.0 | 8.9 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
3.0 | 8.9 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
2.9 | 5.9 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
2.9 | 5.8 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
2.9 | 26.1 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
2.9 | 5.8 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
2.9 | 8.7 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
2.9 | 11.5 | GO:0003166 | bundle of His development(GO:0003166) |
2.9 | 60.0 | GO:0001945 | lymph vessel development(GO:0001945) |
2.8 | 8.3 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
2.8 | 16.6 | GO:0048539 | bone marrow development(GO:0048539) |
2.7 | 8.2 | GO:0036394 | amylase secretion(GO:0036394) |
2.7 | 19.1 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
2.7 | 8.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
2.7 | 13.5 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
2.7 | 5.4 | GO:0072125 | negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
2.7 | 10.8 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
2.7 | 10.7 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
2.7 | 16.0 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
2.6 | 15.8 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
2.6 | 10.6 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
2.6 | 5.3 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
2.6 | 2.6 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
2.6 | 26.0 | GO:0032060 | bleb assembly(GO:0032060) |
2.6 | 2.6 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
2.6 | 7.8 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
2.5 | 7.6 | GO:0060591 | chondroblast differentiation(GO:0060591) |
2.5 | 12.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
2.5 | 7.6 | GO:0060594 | mammary gland specification(GO:0060594) |
2.5 | 27.6 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
2.5 | 10.0 | GO:1903011 | negative regulation of bone development(GO:1903011) |
2.5 | 7.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
2.5 | 32.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
2.5 | 12.4 | GO:0071918 | urea transmembrane transport(GO:0071918) |
2.5 | 4.9 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
2.4 | 19.5 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
2.4 | 14.5 | GO:0060539 | diaphragm development(GO:0060539) |
2.4 | 4.8 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
2.4 | 12.0 | GO:0072675 | osteoclast fusion(GO:0072675) |
2.4 | 9.6 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
2.4 | 7.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
2.4 | 7.1 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
2.4 | 9.5 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
2.4 | 4.7 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
2.3 | 4.6 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
2.3 | 6.9 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
2.3 | 6.8 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
2.3 | 6.8 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
2.3 | 2.3 | GO:0060462 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
2.3 | 15.8 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
2.3 | 6.8 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
2.2 | 6.7 | GO:0007403 | glial cell fate determination(GO:0007403) |
2.2 | 26.9 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
2.2 | 2.2 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
2.2 | 8.9 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
2.2 | 6.7 | GO:0050955 | thermoception(GO:0050955) |
2.2 | 2.2 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) |
2.2 | 4.4 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
2.2 | 8.8 | GO:0018214 | protein carboxylation(GO:0018214) |
2.2 | 6.6 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
2.2 | 4.4 | GO:0044351 | macropinocytosis(GO:0044351) |
2.2 | 8.7 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
2.2 | 4.3 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
2.2 | 6.5 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
2.2 | 15.2 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
2.2 | 4.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
2.2 | 6.5 | GO:0060057 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
2.1 | 15.0 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
2.1 | 2.1 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
2.1 | 4.3 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) positive regulation of glucose mediated signaling pathway(GO:1902661) |
2.1 | 6.4 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
2.1 | 8.5 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
2.1 | 10.6 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
2.1 | 6.3 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
2.1 | 16.8 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
2.1 | 18.9 | GO:0071361 | cellular response to ethanol(GO:0071361) |
2.1 | 2.1 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
2.1 | 6.3 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
2.1 | 6.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
2.1 | 2.1 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
2.1 | 10.4 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
2.1 | 2.1 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
2.1 | 2.1 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
2.0 | 10.2 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
2.0 | 6.1 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
2.0 | 8.1 | GO:0001842 | neural fold formation(GO:0001842) |
2.0 | 2.0 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
2.0 | 10.0 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
2.0 | 6.0 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
2.0 | 4.0 | GO:0034391 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
2.0 | 6.0 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
2.0 | 8.0 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
2.0 | 4.0 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
2.0 | 3.9 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
2.0 | 3.9 | GO:0030104 | water homeostasis(GO:0030104) |
1.9 | 3.8 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
1.9 | 15.4 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
1.9 | 3.8 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.9 | 3.8 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.9 | 30.5 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
1.9 | 11.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
1.9 | 7.6 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
1.9 | 11.4 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
1.9 | 7.6 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.9 | 3.8 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
1.9 | 5.6 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.9 | 5.6 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
1.9 | 3.7 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.8 | 31.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
1.8 | 7.4 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
1.8 | 18.4 | GO:0009404 | toxin metabolic process(GO:0009404) |
1.8 | 5.5 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
1.8 | 5.5 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
1.8 | 3.6 | GO:0046877 | regulation of saliva secretion(GO:0046877) positive regulation of saliva secretion(GO:0046878) |
1.8 | 3.6 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
1.8 | 9.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
1.8 | 10.8 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
1.8 | 8.9 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
1.8 | 10.7 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
1.8 | 5.3 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.8 | 3.5 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
1.8 | 10.6 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
1.8 | 1.8 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
1.7 | 5.2 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
1.7 | 7.0 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
1.7 | 17.3 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
1.7 | 8.6 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
1.7 | 10.3 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
1.7 | 8.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
1.7 | 3.4 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
1.7 | 3.4 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
1.7 | 5.1 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
1.7 | 1.7 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
1.7 | 18.6 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
1.7 | 10.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
1.7 | 13.5 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
1.7 | 5.1 | GO:0002159 | desmosome assembly(GO:0002159) |
1.7 | 6.7 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
1.7 | 5.0 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
1.7 | 5.0 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
1.7 | 10.0 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
1.7 | 8.3 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
1.7 | 3.3 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
1.7 | 9.9 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
1.6 | 28.0 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
1.6 | 6.5 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
1.6 | 6.5 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
1.6 | 29.0 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
1.6 | 6.4 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
1.6 | 8.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
1.6 | 1.6 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
1.6 | 3.2 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
1.6 | 6.3 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
1.6 | 4.7 | GO:0071316 | cellular response to nicotine(GO:0071316) |
1.6 | 4.7 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
1.6 | 1.6 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
1.6 | 4.7 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
1.6 | 7.8 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
1.6 | 21.9 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
1.6 | 3.1 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
1.5 | 13.8 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
1.5 | 3.1 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
1.5 | 3.1 | GO:0007494 | midgut development(GO:0007494) |
1.5 | 4.6 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.5 | 1.5 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
1.5 | 13.7 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
1.5 | 3.0 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
1.5 | 4.5 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
1.5 | 3.0 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
1.5 | 4.5 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
1.5 | 4.5 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
1.5 | 4.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
1.5 | 3.0 | GO:0038084 | vascular endothelial growth factor signaling pathway(GO:0038084) |
1.5 | 5.9 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
1.5 | 13.3 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
1.5 | 4.4 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
1.5 | 8.8 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
1.5 | 4.4 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
1.5 | 5.8 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
1.5 | 59.8 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
1.5 | 7.3 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
1.5 | 2.9 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
1.5 | 7.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.4 | 2.9 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
1.4 | 10.0 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
1.4 | 1.4 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
1.4 | 34.0 | GO:0006270 | DNA replication initiation(GO:0006270) |
1.4 | 4.2 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.4 | 2.8 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
1.4 | 11.3 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
1.4 | 5.6 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
1.4 | 2.8 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
1.4 | 1.4 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
1.4 | 4.2 | GO:0060596 | mammary gland formation(GO:0060592) mammary placode formation(GO:0060596) |
1.4 | 4.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
1.4 | 4.2 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
1.4 | 6.9 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
1.4 | 5.5 | GO:0045402 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
1.4 | 9.7 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
1.4 | 4.1 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
1.4 | 5.5 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
1.4 | 8.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
1.4 | 2.7 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
1.4 | 4.1 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
1.4 | 2.7 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
1.4 | 6.8 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
1.4 | 4.1 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
1.4 | 12.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
1.4 | 10.8 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
1.3 | 4.0 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
1.3 | 10.8 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
1.3 | 6.7 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
1.3 | 1.3 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
1.3 | 12.0 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
1.3 | 2.7 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
1.3 | 9.3 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
1.3 | 4.0 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
1.3 | 10.5 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
1.3 | 29.0 | GO:0030199 | collagen fibril organization(GO:0030199) |
1.3 | 7.9 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
1.3 | 6.6 | GO:0080154 | regulation of fertilization(GO:0080154) |
1.3 | 3.9 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
1.3 | 2.6 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
1.3 | 5.2 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
1.3 | 3.9 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
1.3 | 2.6 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
1.3 | 5.2 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) |
1.3 | 6.5 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
1.3 | 1.3 | GO:0002444 | myeloid leukocyte mediated immunity(GO:0002444) |
1.3 | 3.9 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
1.3 | 12.9 | GO:0032801 | receptor catabolic process(GO:0032801) |
1.3 | 1.3 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
1.3 | 3.9 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
1.3 | 3.8 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
1.3 | 5.1 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
1.3 | 2.6 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
1.3 | 8.9 | GO:0008343 | adult feeding behavior(GO:0008343) |
1.3 | 3.8 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
1.3 | 8.9 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
1.3 | 1.3 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
1.3 | 1.3 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
1.3 | 1.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
1.3 | 3.8 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
1.3 | 5.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
1.3 | 7.6 | GO:0071318 | cellular response to ATP(GO:0071318) |
1.3 | 10.1 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
1.3 | 2.5 | GO:0032799 | low-density lipoprotein receptor particle metabolic process(GO:0032799) |
1.3 | 13.9 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
1.3 | 27.7 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
1.3 | 3.8 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) |
1.3 | 1.3 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
1.3 | 3.8 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
1.3 | 2.5 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
1.3 | 1.3 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
1.3 | 1.3 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
1.3 | 6.3 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
1.2 | 2.5 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
1.2 | 2.5 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
1.2 | 13.7 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
1.2 | 2.5 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
1.2 | 2.5 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
1.2 | 8.7 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
1.2 | 2.5 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
1.2 | 2.5 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
1.2 | 3.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.2 | 6.1 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
1.2 | 11.0 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
1.2 | 2.4 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
1.2 | 4.9 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
1.2 | 1.2 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
1.2 | 4.9 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
1.2 | 3.6 | GO:0006083 | acetate metabolic process(GO:0006083) |
1.2 | 4.8 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
1.2 | 3.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.2 | 2.4 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
1.2 | 1.2 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
1.2 | 1.2 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
1.2 | 2.4 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
1.2 | 3.6 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
1.2 | 2.4 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
1.2 | 15.5 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
1.2 | 2.4 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.2 | 3.6 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) |
1.2 | 3.6 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
1.2 | 3.6 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
1.2 | 2.4 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
1.2 | 28.3 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
1.2 | 1.2 | GO:0032344 | regulation of aldosterone metabolic process(GO:0032344) |
1.2 | 7.0 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
1.2 | 5.9 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
1.2 | 16.4 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
1.2 | 4.7 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
1.2 | 19.8 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
1.2 | 4.7 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
1.2 | 5.8 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
1.2 | 3.5 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
1.2 | 2.3 | GO:0006551 | leucine metabolic process(GO:0006551) |
1.2 | 4.6 | GO:0060283 | negative regulation of oocyte development(GO:0060283) |
1.2 | 2.3 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
1.2 | 3.5 | GO:0034637 | cellular carbohydrate biosynthetic process(GO:0034637) |
1.1 | 4.6 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
1.1 | 1.1 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) nephrogenic mesenchyme development(GO:0072076) |
1.1 | 3.4 | GO:0000087 | mitotic M phase(GO:0000087) |
1.1 | 1.1 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
1.1 | 1.1 | GO:1900368 | regulation of RNA interference(GO:1900368) |
1.1 | 3.4 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
1.1 | 6.8 | GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
1.1 | 5.7 | GO:0033623 | regulation of integrin activation(GO:0033623) |
1.1 | 1.1 | GO:0014029 | neural crest formation(GO:0014029) |
1.1 | 23.7 | GO:0006301 | postreplication repair(GO:0006301) |
1.1 | 3.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
1.1 | 4.5 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
1.1 | 4.5 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
1.1 | 2.3 | GO:0097491 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
1.1 | 3.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.1 | 1.1 | GO:0010159 | specification of organ position(GO:0010159) |
1.1 | 2.2 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
1.1 | 1.1 | GO:0043366 | beta selection(GO:0043366) |
1.1 | 25.6 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
1.1 | 2.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
1.1 | 4.4 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
1.1 | 4.4 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
1.1 | 2.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.1 | 1.1 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
1.1 | 2.2 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.1 | 1.1 | GO:0055093 | cellular response to increased oxygen levels(GO:0036295) response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) cellular response to hyperoxia(GO:0071455) |
1.1 | 25.3 | GO:0014823 | response to activity(GO:0014823) |
1.1 | 6.6 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
1.1 | 3.3 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
1.1 | 3.3 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
1.1 | 7.6 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
1.1 | 4.3 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
1.1 | 11.8 | GO:0000303 | response to superoxide(GO:0000303) |
1.1 | 2.1 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
1.1 | 5.4 | GO:0030318 | melanocyte differentiation(GO:0030318) |
1.1 | 1.1 | GO:2000738 | positive regulation of stem cell differentiation(GO:2000738) |
1.1 | 1.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
1.1 | 17.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
1.1 | 3.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
1.1 | 3.2 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.1 | 1.1 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
1.1 | 7.4 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
1.1 | 1.1 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
1.0 | 1.0 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
1.0 | 3.1 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
1.0 | 1.0 | GO:0060023 | soft palate development(GO:0060023) |
1.0 | 6.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
1.0 | 10.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
1.0 | 7.2 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
1.0 | 2.0 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
1.0 | 3.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
1.0 | 4.1 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
1.0 | 9.2 | GO:0009437 | carnitine metabolic process(GO:0009437) |
1.0 | 3.1 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
1.0 | 2.0 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
1.0 | 5.1 | GO:0016266 | O-glycan processing(GO:0016266) |
1.0 | 4.0 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
1.0 | 2.0 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
1.0 | 1.0 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
1.0 | 4.0 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
1.0 | 3.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
1.0 | 8.1 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
1.0 | 5.0 | GO:0000237 | leptotene(GO:0000237) |
1.0 | 21.2 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
1.0 | 2.0 | GO:0035973 | aggrephagy(GO:0035973) |
1.0 | 2.0 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
1.0 | 4.0 | GO:0070995 | NADPH oxidation(GO:0070995) |
1.0 | 11.0 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
1.0 | 2.0 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
1.0 | 2.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.0 | 5.0 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
1.0 | 3.0 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
1.0 | 3.0 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
1.0 | 1.0 | GO:0035931 | renin-angiotensin regulation of aldosterone production(GO:0002018) mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
1.0 | 22.7 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
1.0 | 6.9 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
1.0 | 1.0 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
1.0 | 1.0 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) |
1.0 | 3.9 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
1.0 | 3.9 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
1.0 | 1.0 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
1.0 | 3.9 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
1.0 | 6.8 | GO:0007144 | female meiosis I(GO:0007144) |
1.0 | 1.0 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
1.0 | 1.0 | GO:0002467 | germinal center formation(GO:0002467) |
1.0 | 1.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
1.0 | 1.9 | GO:0071895 | odontoblast differentiation(GO:0071895) |
1.0 | 1.9 | GO:0048733 | sebaceous gland development(GO:0048733) |
1.0 | 7.7 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
1.0 | 1.0 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
1.0 | 2.9 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
1.0 | 2.9 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
1.0 | 4.8 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
1.0 | 2.9 | GO:0016264 | gap junction assembly(GO:0016264) |
1.0 | 7.7 | GO:0007097 | nuclear migration(GO:0007097) |
1.0 | 1.0 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.0 | 4.8 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
1.0 | 1.0 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.9 | 4.7 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
0.9 | 0.9 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.9 | 2.8 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.9 | 1.9 | GO:0001757 | somite specification(GO:0001757) |
0.9 | 2.8 | GO:0031508 | chromatin remodeling at centromere(GO:0031055) pericentric heterochromatin assembly(GO:0031508) |
0.9 | 0.9 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
0.9 | 1.9 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.9 | 12.2 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.9 | 2.8 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.9 | 2.8 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.9 | 3.8 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) |
0.9 | 3.8 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.9 | 0.9 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.9 | 8.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.9 | 7.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.9 | 11.0 | GO:0050879 | skeletal muscle contraction(GO:0003009) multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
0.9 | 4.6 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.9 | 0.9 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.9 | 0.9 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.9 | 5.5 | GO:0090196 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
0.9 | 3.7 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.9 | 0.9 | GO:0060435 | bronchiole development(GO:0060435) |
0.9 | 5.4 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.9 | 6.3 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.9 | 4.5 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.9 | 0.9 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.9 | 4.5 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.9 | 3.6 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.9 | 0.9 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.9 | 3.6 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.9 | 1.8 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.9 | 5.3 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.9 | 2.7 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.9 | 1.8 | GO:2000758 | positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.9 | 2.6 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.9 | 14.1 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.9 | 0.9 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.9 | 2.6 | GO:0035106 | operant conditioning(GO:0035106) |
0.9 | 1.8 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
0.9 | 0.9 | GO:0051182 | coenzyme transport(GO:0051182) |
0.9 | 4.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.9 | 1.7 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.9 | 1.7 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.9 | 0.9 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.9 | 2.6 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
0.9 | 1.7 | GO:1903911 | positive regulation of receptor clustering(GO:1903911) |
0.9 | 2.6 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.9 | 3.5 | GO:1904752 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.9 | 20.6 | GO:0007520 | myoblast fusion(GO:0007520) |
0.9 | 0.9 | GO:0060065 | uterus development(GO:0060065) |
0.9 | 6.0 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.9 | 4.3 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.8 | 0.8 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.8 | 1.7 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.8 | 1.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.8 | 1.7 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.8 | 0.8 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.8 | 1.7 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.8 | 0.8 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.8 | 0.8 | GO:0033058 | directional locomotion(GO:0033058) |
0.8 | 0.8 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.8 | 5.0 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.8 | 5.8 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.8 | 3.3 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.8 | 0.8 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.8 | 1.6 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.8 | 2.5 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.8 | 5.7 | GO:0043586 | tongue development(GO:0043586) |
0.8 | 2.5 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.8 | 5.7 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.8 | 7.3 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.8 | 4.9 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.8 | 1.6 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.8 | 8.1 | GO:1902743 | regulation of lamellipodium organization(GO:1902743) |
0.8 | 0.8 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.8 | 4.1 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.8 | 0.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.8 | 1.6 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.8 | 3.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.8 | 2.4 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
0.8 | 4.0 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.8 | 11.3 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.8 | 1.6 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
0.8 | 0.8 | GO:0071335 | hair follicle cell proliferation(GO:0071335) |
0.8 | 3.2 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.8 | 0.8 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.8 | 3.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.8 | 4.0 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.8 | 68.5 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.8 | 2.4 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.8 | 0.8 | GO:1903393 | positive regulation of adherens junction organization(GO:1903393) |
0.8 | 3.9 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.8 | 1.6 | GO:0007442 | hindgut morphogenesis(GO:0007442) |
0.8 | 0.8 | GO:0018343 | protein farnesylation(GO:0018343) |
0.8 | 2.3 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.8 | 1.6 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.8 | 0.8 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.8 | 0.8 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.8 | 3.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.8 | 14.0 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.8 | 3.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.8 | 2.3 | GO:0030576 | Cajal body organization(GO:0030576) |
0.8 | 7.0 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.8 | 3.9 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.8 | 13.9 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.8 | 2.3 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
0.8 | 2.3 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.8 | 2.3 | GO:0015819 | lysine transport(GO:0015819) |
0.8 | 5.4 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.8 | 3.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.8 | 2.3 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.8 | 16.9 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.8 | 3.1 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.8 | 0.8 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.8 | 3.1 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.8 | 5.4 | GO:0050957 | equilibrioception(GO:0050957) |
0.8 | 0.8 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.8 | 1.5 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.8 | 2.3 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.8 | 1.5 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.8 | 1.5 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.8 | 4.5 | GO:0007398 | ectoderm development(GO:0007398) |
0.8 | 3.8 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.8 | 1.5 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.8 | 0.8 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.8 | 3.8 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.8 | 8.3 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.7 | 3.0 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.7 | 4.5 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.7 | 2.2 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.7 | 3.7 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.7 | 2.2 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.7 | 3.7 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.7 | 1.5 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.7 | 0.7 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.7 | 4.5 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.7 | 8.2 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.7 | 1.5 | GO:2000756 | regulation of histone acetylation(GO:0035065) regulation of peptidyl-lysine acetylation(GO:2000756) |
0.7 | 1.5 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.7 | 2.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.7 | 3.0 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.7 | 0.7 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.7 | 3.0 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.7 | 1.5 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.7 | 2.2 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.7 | 2.2 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.7 | 2.2 | GO:0030033 | microvillus assembly(GO:0030033) |
0.7 | 1.5 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.7 | 0.7 | GO:0070920 | regulation of production of small RNA involved in gene silencing by RNA(GO:0070920) |
0.7 | 0.7 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.7 | 2.9 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.7 | 2.2 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.7 | 0.7 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.7 | 0.7 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.7 | 1.5 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.7 | 6.5 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.7 | 0.7 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.7 | 5.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.7 | 1.4 | GO:1902075 | cellular response to salt(GO:1902075) |
0.7 | 0.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.7 | 3.6 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.7 | 2.9 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.7 | 5.8 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.7 | 0.7 | GO:0033483 | gas homeostasis(GO:0033483) |
0.7 | 2.2 | GO:0006560 | proline metabolic process(GO:0006560) |
0.7 | 2.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.7 | 2.9 | GO:0002760 | positive regulation of antimicrobial humoral response(GO:0002760) |
0.7 | 2.1 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.7 | 2.1 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.7 | 5.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.7 | 2.8 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.7 | 14.9 | GO:0070527 | platelet aggregation(GO:0070527) |
0.7 | 0.7 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.7 | 1.4 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.7 | 1.4 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.7 | 1.4 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.7 | 6.3 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.7 | 2.1 | GO:0042737 | drug catabolic process(GO:0042737) |
0.7 | 7.0 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.7 | 0.7 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.7 | 2.1 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.7 | 0.7 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.7 | 1.4 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.7 | 0.7 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.7 | 1.4 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.7 | 25.1 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.7 | 0.7 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.7 | 1.4 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.7 | 0.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.7 | 2.1 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.7 | 2.1 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.7 | 1.4 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.7 | 0.7 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.7 | 0.7 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.7 | 1.4 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.7 | 4.1 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.7 | 3.4 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.7 | 8.1 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.7 | 13.6 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.7 | 0.7 | GO:0070671 | response to interleukin-12(GO:0070671) |
0.7 | 1.4 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.7 | 2.0 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) Schwann cell proliferation(GO:0014010) |
0.7 | 1.4 | GO:0015889 | cobalamin transport(GO:0015889) |
0.7 | 3.4 | GO:0051775 | response to redox state(GO:0051775) |
0.7 | 2.0 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.7 | 3.4 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.7 | 2.0 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.7 | 1.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.7 | 3.3 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.7 | 8.7 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.7 | 0.7 | GO:0090504 | epiboly(GO:0090504) |
0.7 | 3.3 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.7 | 2.7 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.7 | 2.6 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.7 | 0.7 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.7 | 3.3 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.7 | 0.7 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.7 | 10.5 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.7 | 2.0 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.7 | 2.0 | GO:1905206 | positive regulation of response to reactive oxygen species(GO:1901033) positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.7 | 0.7 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.7 | 0.7 | GO:0072319 | clathrin coat disassembly(GO:0072318) vesicle uncoating(GO:0072319) |
0.7 | 0.7 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.7 | 2.0 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.7 | 0.7 | GO:1901623 | regulation of lymphocyte chemotaxis(GO:1901623) |
0.7 | 7.8 | GO:0045116 | protein neddylation(GO:0045116) |
0.7 | 0.7 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.6 | 5.2 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.6 | 1.9 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.6 | 1.9 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.6 | 0.6 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.6 | 1.3 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.6 | 1.3 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.6 | 2.6 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.6 | 2.6 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.6 | 0.6 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.6 | 3.9 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.6 | 3.2 | GO:0098722 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) asymmetric stem cell division(GO:0098722) germline stem cell asymmetric division(GO:0098728) |
0.6 | 0.6 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.6 | 1.3 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.6 | 1.3 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.6 | 5.1 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.6 | 3.2 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.6 | 3.8 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.6 | 1.3 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.6 | 11.5 | GO:0032456 | endocytic recycling(GO:0032456) |
0.6 | 3.8 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.6 | 1.9 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.6 | 7.0 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.6 | 0.6 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.6 | 4.4 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.6 | 5.7 | GO:0002076 | osteoblast development(GO:0002076) |
0.6 | 10.7 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.6 | 3.8 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.6 | 1.3 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
0.6 | 0.6 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.6 | 1.3 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.6 | 0.6 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.6 | 1.2 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.6 | 0.6 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.6 | 2.5 | GO:0018101 | protein citrullination(GO:0018101) |
0.6 | 0.6 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.6 | 0.6 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.6 | 1.2 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.6 | 1.9 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.6 | 0.6 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.6 | 3.7 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.6 | 1.2 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
0.6 | 0.6 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.6 | 2.5 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.6 | 1.9 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.6 | 5.6 | GO:0006825 | copper ion transport(GO:0006825) |
0.6 | 1.9 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.6 | 3.1 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.6 | 0.6 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.6 | 1.8 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.6 | 5.5 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.6 | 1.2 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.6 | 0.6 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.6 | 0.6 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.6 | 9.7 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.6 | 3.0 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.6 | 0.6 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.6 | 1.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.6 | 3.0 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.6 | 1.2 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.6 | 1.8 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.6 | 4.8 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
0.6 | 6.0 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.6 | 0.6 | GO:0010255 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.6 | 1.8 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.6 | 1.8 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.6 | 2.4 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.6 | 0.6 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.6 | 1.8 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.6 | 1.8 | GO:0032439 | endosome localization(GO:0032439) |
0.6 | 2.4 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.6 | 2.4 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.6 | 1.2 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.6 | 0.6 | GO:0071888 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.6 | 1.8 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.6 | 1.8 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.6 | 1.2 | GO:0044849 | estrous cycle(GO:0044849) |
0.6 | 1.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.6 | 1.2 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.6 | 0.6 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.6 | 1.8 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.6 | 2.4 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.6 | 1.2 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.6 | 4.1 | GO:0036093 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
0.6 | 1.8 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.6 | 1.2 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.6 | 1.8 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.6 | 5.8 | GO:0001706 | endoderm formation(GO:0001706) |
0.6 | 7.0 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.6 | 0.6 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.6 | 9.9 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.6 | 3.5 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.6 | 3.5 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.6 | 1.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.6 | 5.2 | GO:0007141 | male meiosis I(GO:0007141) |
0.6 | 2.9 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.6 | 0.6 | GO:0033572 | transferrin transport(GO:0033572) |
0.6 | 0.6 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.6 | 1.1 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.6 | 2.9 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.6 | 1.7 | GO:0015671 | oxygen transport(GO:0015671) |
0.6 | 2.8 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.6 | 1.7 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.6 | 1.1 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.6 | 0.6 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.6 | 1.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.6 | 2.8 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.6 | 0.6 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.6 | 1.7 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.6 | 12.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.6 | 2.8 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.6 | 9.5 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.6 | 2.2 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.6 | 2.8 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.6 | 1.7 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.6 | 2.2 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.6 | 1.1 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.6 | 1.1 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.6 | 1.7 | GO:0018158 | protein oxidation(GO:0018158) |
0.6 | 1.1 | GO:0042628 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.6 | 1.7 | GO:0021534 | cell proliferation in hindbrain(GO:0021534) cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.6 | 1.7 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.6 | 0.6 | GO:0030578 | PML body organization(GO:0030578) |
0.6 | 4.4 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.6 | 1.7 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.6 | 1.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.5 | 1.1 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.5 | 11.5 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.5 | 4.4 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.5 | 1.1 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.5 | 4.4 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.5 | 1.6 | GO:0071559 | response to transforming growth factor beta(GO:0071559) |
0.5 | 3.3 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.5 | 2.2 | GO:0048524 | positive regulation of viral process(GO:0048524) |
0.5 | 1.1 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.5 | 0.5 | GO:0015744 | succinate transport(GO:0015744) |
0.5 | 4.9 | GO:0030038 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.5 | 0.5 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.5 | 1.1 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.5 | 3.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.5 | 11.8 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.5 | 2.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.5 | 6.4 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.5 | 0.5 | GO:0001555 | oocyte growth(GO:0001555) |
0.5 | 1.1 | GO:0035733 | hepatic stellate cell activation(GO:0035733) |
0.5 | 1.1 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.5 | 13.3 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.5 | 0.5 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.5 | 13.2 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.5 | 2.6 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.5 | 1.1 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.5 | 1.1 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.5 | 2.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.5 | 2.1 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.5 | 1.1 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.5 | 1.6 | GO:0070873 | regulation of glycogen metabolic process(GO:0070873) |
0.5 | 4.2 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.5 | 1.1 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.5 | 3.2 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.5 | 22.0 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.5 | 9.4 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.5 | 1.6 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.5 | 0.5 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.5 | 1.0 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.5 | 2.1 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.5 | 2.1 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.5 | 1.0 | GO:0048069 | eye pigmentation(GO:0048069) |
0.5 | 1.5 | GO:0060669 | embryonic placenta morphogenesis(GO:0060669) |
0.5 | 1.5 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.5 | 2.0 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.5 | 1.0 | GO:0060903 | regulation of meiosis I(GO:0060631) positive regulation of meiosis I(GO:0060903) |
0.5 | 0.5 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.5 | 6.1 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.5 | 0.5 | GO:0001993 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine(GO:0001993) |
0.5 | 0.5 | GO:0070459 | prolactin secretion(GO:0070459) |
0.5 | 1.5 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.5 | 5.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.5 | 1.5 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.5 | 1.5 | GO:0030575 | nuclear body organization(GO:0030575) |
0.5 | 10.1 | GO:0001889 | liver development(GO:0001889) |
0.5 | 2.0 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.5 | 1.5 | GO:1903232 | melanosome assembly(GO:1903232) |
0.5 | 0.5 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.5 | 1.5 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.5 | 1.5 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.5 | 2.5 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.5 | 1.0 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.5 | 11.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.5 | 2.0 | GO:0001759 | organ induction(GO:0001759) |
0.5 | 1.0 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.5 | 3.0 | GO:0060736 | prostate gland growth(GO:0060736) |
0.5 | 7.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.5 | 1.5 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.5 | 3.0 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.5 | 2.0 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.5 | 2.0 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.5 | 0.5 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.5 | 1.5 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.5 | 1.5 | GO:0098927 | vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.5 | 9.5 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.5 | 0.5 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.5 | 1.5 | GO:0043633 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.5 | 1.5 | GO:0070842 | aggresome assembly(GO:0070842) |
0.5 | 4.0 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.5 | 4.0 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.5 | 6.9 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.5 | 2.0 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.5 | 3.0 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.5 | 1.5 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.5 | 2.0 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.5 | 2.0 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.5 | 0.5 | GO:1902566 | regulation of eosinophil activation(GO:1902566) |
0.5 | 2.9 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
0.5 | 1.5 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.5 | 1.5 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.5 | 2.9 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.5 | 0.5 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.5 | 0.5 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.5 | 0.5 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.5 | 1.5 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.5 | 30.9 | GO:0030198 | extracellular matrix organization(GO:0030198) |
0.5 | 7.2 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.5 | 0.5 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.5 | 0.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.5 | 1.4 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.5 | 1.0 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.5 | 6.7 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.5 | 1.9 | GO:0002477 | antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
0.5 | 2.9 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.5 | 25.8 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.5 | 1.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.5 | 3.3 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.5 | 3.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.5 | 3.3 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.5 | 1.4 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.5 | 0.5 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.5 | 0.9 | GO:0050820 | positive regulation of coagulation(GO:0050820) |
0.5 | 0.5 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.5 | 0.9 | GO:0048478 | replication fork protection(GO:0048478) |
0.5 | 2.8 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.5 | 2.8 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.5 | 2.3 | GO:0046836 | glycolipid transport(GO:0046836) |
0.5 | 0.5 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.5 | 5.1 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.5 | 1.9 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.5 | 9.3 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.5 | 1.4 | GO:2000303 | regulation of sphingolipid biosynthetic process(GO:0090153) negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
0.5 | 0.5 | GO:0090148 | membrane fission(GO:0090148) |
0.5 | 2.8 | GO:0051231 | spindle elongation(GO:0051231) |
0.5 | 1.4 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.5 | 0.9 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.5 | 0.5 | GO:0019627 | arginine biosynthetic process(GO:0006526) urea metabolic process(GO:0019627) |
0.5 | 2.8 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.5 | 0.5 | GO:0010226 | response to lithium ion(GO:0010226) |
0.5 | 0.5 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.5 | 1.8 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.5 | 1.4 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.5 | 2.3 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.5 | 0.5 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.5 | 1.8 | GO:0031100 | organ regeneration(GO:0031100) |
0.5 | 5.4 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.5 | 0.9 | GO:0043084 | penile erection(GO:0043084) |
0.5 | 1.4 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.5 | 0.9 | GO:0071295 | cellular response to vitamin(GO:0071295) |
0.4 | 3.6 | GO:0045214 | sarcomere organization(GO:0045214) |
0.4 | 0.4 | GO:0003272 | endocardial cushion formation(GO:0003272) |
0.4 | 0.9 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.4 | 10.6 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.4 | 4.9 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.4 | 3.1 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.4 | 0.9 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.4 | 0.4 | GO:1901722 | regulation of cell proliferation involved in kidney development(GO:1901722) |
0.4 | 0.4 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.4 | 1.8 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.4 | 1.3 | GO:0015817 | histidine transport(GO:0015817) |
0.4 | 3.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.4 | 1.7 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.4 | 2.2 | GO:0032402 | melanosome transport(GO:0032402) |
0.4 | 1.7 | GO:0097286 | iron ion import(GO:0097286) |
0.4 | 1.3 | GO:0038202 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) |
0.4 | 6.5 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.4 | 0.9 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.4 | 0.9 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.4 | 0.4 | GO:0010986 | regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of lipoprotein particle clearance(GO:0010986) |
0.4 | 0.4 | GO:0072718 | response to cisplatin(GO:0072718) |
0.4 | 3.9 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.4 | 0.4 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.4 | 1.7 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.4 | 0.4 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.4 | 1.7 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.4 | 1.7 | GO:0032196 | transposition(GO:0032196) |
0.4 | 2.5 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.4 | 0.8 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.4 | 0.4 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.4 | 0.4 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.4 | 2.9 | GO:0061756 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.4 | 2.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.4 | 0.4 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.4 | 3.8 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.4 | 1.3 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.4 | 2.1 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.4 | 0.4 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.4 | 0.4 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.4 | 0.4 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.4 | 2.5 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.4 | 1.2 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.4 | 2.5 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.4 | 0.4 | GO:0060442 | branching involved in prostate gland morphogenesis(GO:0060442) |
0.4 | 0.8 | GO:0010470 | regulation of gastrulation(GO:0010470) |
0.4 | 0.8 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.4 | 2.1 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.4 | 0.8 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.4 | 11.1 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.4 | 7.8 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.4 | 1.6 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.4 | 2.5 | GO:0070633 | transepithelial transport(GO:0070633) |
0.4 | 0.8 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.4 | 0.8 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.4 | 0.4 | GO:0043489 | RNA stabilization(GO:0043489) |
0.4 | 7.7 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.4 | 0.4 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.4 | 3.2 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.4 | 1.2 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.4 | 1.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.4 | 3.6 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.4 | 2.4 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.4 | 1.2 | GO:0072224 | metanephric glomerulus development(GO:0072224) |
0.4 | 1.2 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.4 | 3.2 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.4 | 0.4 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.4 | 1.2 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.4 | 1.2 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.4 | 0.8 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.4 | 1.6 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.4 | 0.8 | GO:0030878 | thyroid gland development(GO:0030878) |
0.4 | 0.8 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.4 | 1.6 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.4 | 0.4 | GO:0090383 | phagosome acidification(GO:0090383) |
0.4 | 1.2 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.4 | 1.2 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.4 | 2.7 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.4 | 2.0 | GO:0034694 | response to prostaglandin(GO:0034694) |
0.4 | 0.4 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.4 | 0.8 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.4 | 0.8 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.4 | 22.1 | GO:0043627 | response to estrogen(GO:0043627) |
0.4 | 1.2 | GO:0016322 | neuron remodeling(GO:0016322) |
0.4 | 1.2 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.4 | 1.2 | GO:0001556 | oocyte maturation(GO:0001556) |
0.4 | 3.1 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
0.4 | 3.1 | GO:0001837 | epithelial to mesenchymal transition(GO:0001837) |
0.4 | 3.1 | GO:0034389 | lipid particle organization(GO:0034389) |
0.4 | 5.0 | GO:1901343 | negative regulation of vasculature development(GO:1901343) |
0.4 | 1.5 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.4 | 1.9 | GO:0051639 | actin filament network formation(GO:0051639) |
0.4 | 0.4 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) |
0.4 | 0.4 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.4 | 0.4 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.4 | 1.1 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.4 | 0.4 | GO:0006901 | vesicle coating(GO:0006901) |
0.4 | 0.8 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.4 | 0.4 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.4 | 0.8 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.4 | 0.8 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.4 | 2.6 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.4 | 0.7 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.4 | 0.4 | GO:2000482 | regulation of interleukin-8 secretion(GO:2000482) |
0.4 | 0.4 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.4 | 4.5 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.4 | 1.1 | GO:0060343 | trabecula formation(GO:0060343) |
0.4 | 7.8 | GO:0030261 | chromosome condensation(GO:0030261) |
0.4 | 6.3 | GO:0060389 | pathway-restricted SMAD protein phosphorylation(GO:0060389) |
0.4 | 1.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.4 | 1.1 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.4 | 0.4 | GO:0019042 | viral latency(GO:0019042) |
0.4 | 0.7 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.4 | 1.8 | GO:0032743 | positive regulation of interleukin-2 production(GO:0032743) |
0.4 | 0.4 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.4 | 7.6 | GO:0007569 | cell aging(GO:0007569) |
0.4 | 0.4 | GO:0006090 | pyruvate metabolic process(GO:0006090) |
0.4 | 0.4 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.4 | 2.2 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.4 | 9.4 | GO:0034620 | cellular response to unfolded protein(GO:0034620) |
0.4 | 1.1 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.4 | 2.9 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.4 | 1.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.4 | 0.4 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.4 | 25.0 | GO:0071219 | cellular response to molecule of bacterial origin(GO:0071219) |
0.4 | 0.4 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.4 | 0.4 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.4 | 6.0 | GO:0032496 | response to lipopolysaccharide(GO:0032496) |
0.4 | 1.1 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.4 | 0.7 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.4 | 0.4 | GO:0043062 | extracellular structure organization(GO:0043062) |
0.4 | 0.7 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.4 | 1.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.4 | 8.5 | GO:0030282 | bone mineralization(GO:0030282) |
0.4 | 1.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.4 | 3.5 | GO:0035050 | embryonic heart tube development(GO:0035050) |
0.4 | 4.2 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
0.4 | 1.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.3 | 2.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.3 | 1.0 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.3 | 1.0 | GO:0006116 | NADH oxidation(GO:0006116) |
0.3 | 0.3 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.3 | 1.7 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.3 | 2.1 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.3 | 0.7 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.3 | 0.7 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.3 | 2.1 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.3 | 6.6 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.3 | 0.7 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.3 | 0.7 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.3 | 0.7 | GO:0030421 | defecation(GO:0030421) |
0.3 | 3.4 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.3 | 2.1 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.3 | 1.7 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.3 | 1.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.3 | 0.7 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.3 | 0.7 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.3 | 2.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.3 | 8.5 | GO:0015914 | phospholipid transport(GO:0015914) |
0.3 | 0.3 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.3 | 1.0 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.3 | 1.7 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.3 | 1.7 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.3 | 0.7 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.3 | 0.7 | GO:0045429 | positive regulation of nitric oxide biosynthetic process(GO:0045429) positive regulation of nitric oxide metabolic process(GO:1904407) |
0.3 | 0.7 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.3 | 1.7 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.3 | 0.7 | GO:0090077 | foam cell differentiation(GO:0090077) |
0.3 | 0.7 | GO:0072553 | terminal button organization(GO:0072553) |
0.3 | 1.0 | GO:0000012 | single strand break repair(GO:0000012) |
0.3 | 2.7 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 2.3 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.3 | 0.7 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.3 | 2.0 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.3 | 5.3 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.3 | 4.0 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.3 | 0.7 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.3 | 4.3 | GO:0050892 | intestinal absorption(GO:0050892) |
0.3 | 0.7 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.3 | 3.9 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.3 | 1.3 | GO:0031167 | rRNA methylation(GO:0031167) |
0.3 | 2.9 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.3 | 0.7 | GO:0010828 | positive regulation of glucose transport(GO:0010828) |
0.3 | 0.3 | GO:0006573 | valine metabolic process(GO:0006573) |
0.3 | 0.7 | GO:0030857 | negative regulation of epithelial cell differentiation(GO:0030857) |
0.3 | 0.3 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.3 | 0.7 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.3 | 4.5 | GO:0048678 | response to axon injury(GO:0048678) |
0.3 | 1.0 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.3 | 6.8 | GO:0031424 | keratinization(GO:0031424) |
0.3 | 0.3 | GO:0051029 | rRNA transport(GO:0051029) |
0.3 | 0.6 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.3 | 1.0 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.3 | 0.3 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.3 | 3.2 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.3 | 1.3 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.3 | 0.6 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.3 | 0.3 | GO:0003209 | cardiac atrium morphogenesis(GO:0003209) |
0.3 | 0.3 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.3 | 0.9 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.3 | 0.3 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.3 | 3.7 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.3 | 1.2 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.3 | 0.9 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.3 | 0.3 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.3 | 0.9 | GO:0019320 | hexose catabolic process(GO:0019320) |
0.3 | 2.4 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.3 | 0.3 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.3 | 4.9 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.3 | 0.3 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.3 | 0.3 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.3 | 0.6 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.3 | 2.1 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.3 | 0.3 | GO:0009994 | oocyte differentiation(GO:0009994) |
0.3 | 2.1 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.3 | 0.6 | GO:0048546 | digestive tract morphogenesis(GO:0048546) |
0.3 | 0.3 | GO:0003266 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) regulation of secondary heart field cardioblast proliferation(GO:0003266) |
0.3 | 0.3 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.3 | 0.9 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.3 | 0.6 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.3 | 0.3 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.3 | 0.3 | GO:0015840 | urea transport(GO:0015840) |
0.3 | 0.9 | GO:0010883 | regulation of lipid storage(GO:0010883) |
0.3 | 0.3 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.3 | 0.3 | GO:0016246 | RNA interference(GO:0016246) |
0.3 | 0.3 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.3 | 1.2 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.3 | 1.2 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.3 | 0.6 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.3 | 5.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.3 | 5.5 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.3 | 2.9 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.3 | 0.3 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.3 | 3.7 | GO:0007032 | endosome organization(GO:0007032) |
0.3 | 0.3 | GO:0061008 | hepaticobiliary system development(GO:0061008) |
0.3 | 0.3 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.3 | 0.6 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.3 | 1.4 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.3 | 0.6 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.3 | 0.6 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.3 | 1.4 | GO:0009642 | response to light intensity(GO:0009642) |
0.3 | 0.3 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.3 | 0.6 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.3 | 4.5 | GO:0030488 | tRNA methylation(GO:0030488) |
0.3 | 0.3 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.3 | 5.3 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.3 | 0.6 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.3 | 5.2 | GO:0007179 | transforming growth factor beta receptor signaling pathway(GO:0007179) |
0.3 | 1.1 | GO:0031648 | protein destabilization(GO:0031648) |
0.3 | 0.6 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.3 | 0.3 | GO:0006925 | inflammatory cell apoptotic process(GO:0006925) |
0.3 | 3.0 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.3 | 8.2 | GO:0006165 | nucleoside diphosphate phosphorylation(GO:0006165) |
0.3 | 1.1 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.3 | 0.3 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.3 | 0.8 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.3 | 0.5 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.3 | 0.5 | GO:0061614 | pri-miRNA transcription from RNA polymerase II promoter(GO:0061614) |
0.3 | 0.5 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.3 | 0.8 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.3 | 0.3 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.3 | 0.5 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.3 | 0.3 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.3 | 0.3 | GO:1902219 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.3 | 0.3 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.3 | 0.3 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.3 | 0.5 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.3 | 1.1 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.3 | 0.5 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.3 | 0.3 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.3 | 0.5 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.3 | 0.3 | GO:0010575 | positive regulation of vascular endothelial growth factor production(GO:0010575) |
0.3 | 0.3 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.3 | 4.1 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.3 | 1.0 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.3 | 0.3 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.3 | 0.3 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) gastro-intestinal system smooth muscle contraction(GO:0014831) |
0.3 | 0.3 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.3 | 0.8 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.3 | 1.3 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.3 | 0.3 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.3 | 1.5 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.2 | 4.2 | GO:0055076 | transition metal ion homeostasis(GO:0055076) |
0.2 | 0.5 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.2 | 2.7 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.2 | 1.0 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.2 | 0.7 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
0.2 | 0.2 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.2 | 0.2 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.2 | 14.7 | GO:0051028 | mRNA transport(GO:0051028) |
0.2 | 0.5 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.2 | 1.2 | GO:0042246 | tissue regeneration(GO:0042246) |
0.2 | 0.2 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.2 | 0.2 | GO:0044838 | cell quiescence(GO:0044838) |
0.2 | 1.0 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.2 | 2.7 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.2 | 0.2 | GO:1905155 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
0.2 | 0.7 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 0.7 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 0.2 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.2 | 0.5 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.2 | 0.7 | GO:0010039 | response to iron ion(GO:0010039) |
0.2 | 0.5 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.2 | 0.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.2 | 0.9 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.2 | 2.1 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.2 | 4.9 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.2 | 1.2 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.2 | 7.2 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.2 | 0.5 | GO:0009624 | response to nematode(GO:0009624) |
0.2 | 1.4 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.2 | 0.7 | GO:0060005 | vestibular reflex(GO:0060005) |
0.2 | 0.7 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.2 | 0.7 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.2 | 0.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.2 | 18.2 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.2 | 1.1 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.2 | 0.4 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.2 | 0.2 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.2 | 1.8 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.2 | 1.3 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.2 | 0.7 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.2 | 2.0 | GO:0006354 | DNA-templated transcription, elongation(GO:0006354) |
0.2 | 0.2 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.2 | 0.9 | GO:0031295 | T cell costimulation(GO:0031295) |
0.2 | 2.2 | GO:0070206 | protein trimerization(GO:0070206) |
0.2 | 1.7 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.2 | 8.9 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.2 | 0.2 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.2 | 0.2 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.2 | 1.5 | GO:1901099 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.2 | 2.6 | GO:1990266 | neutrophil migration(GO:1990266) |
0.2 | 0.9 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 0.6 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.2 | 0.6 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.2 | 0.4 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.2 | 0.4 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.2 | 0.2 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.2 | 0.6 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.2 | 0.2 | GO:0034405 | response to fluid shear stress(GO:0034405) cellular response to fluid shear stress(GO:0071498) |
0.2 | 0.2 | GO:0003094 | glomerular filtration(GO:0003094) |
0.2 | 0.2 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.2 | 0.2 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.2 | 0.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 1.3 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.2 | 0.6 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.2 | 0.6 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.2 | 6.1 | GO:0045444 | fat cell differentiation(GO:0045444) |
0.2 | 0.6 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.2 | 0.4 | GO:0009249 | protein lipoylation(GO:0009249) |
0.2 | 0.2 | GO:1900376 | regulation of melanin biosynthetic process(GO:0048021) negative regulation of melanin biosynthetic process(GO:0048022) regulation of secondary metabolite biosynthetic process(GO:1900376) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.2 | 0.6 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.2 | 3.5 | GO:0007340 | acrosome reaction(GO:0007340) |
0.2 | 0.2 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.2 | 0.8 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.2 | 0.4 | GO:0051177 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.2 | 0.2 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.2 | 1.0 | GO:0032986 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.2 | 0.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.2 | 0.8 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.2 | 9.6 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.2 | 1.2 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.2 | 0.2 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.2 | 0.4 | GO:0071800 | podosome assembly(GO:0071800) |
0.2 | 0.2 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.2 | 0.4 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
0.2 | 0.6 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.2 | 0.6 | GO:0042107 | cytokine metabolic process(GO:0042107) |
0.2 | 0.2 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.2 | 1.0 | GO:0034397 | telomere localization(GO:0034397) |
0.2 | 0.6 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 3.1 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.2 | 0.8 | GO:0071216 | cellular response to biotic stimulus(GO:0071216) |
0.2 | 1.7 | GO:1904029 | regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.2 | 0.6 | GO:0035886 | vascular smooth muscle cell differentiation(GO:0035886) |
0.2 | 0.2 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.2 | 0.2 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.2 | 0.2 | GO:0030238 | male sex determination(GO:0030238) |
0.2 | 0.6 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.2 | 1.7 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.2 | 0.6 | GO:1902572 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.2 | 0.4 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.2 | 0.7 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.2 | 1.1 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.2 | 0.9 | GO:0051299 | centrosome separation(GO:0051299) |
0.2 | 0.2 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.2 | 0.2 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.2 | 0.4 | GO:0050996 | positive regulation of lipid catabolic process(GO:0050996) |
0.2 | 0.2 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.2 | 2.0 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.2 | 0.4 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.2 | 1.3 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.2 | 0.4 | GO:0006907 | pinocytosis(GO:0006907) |
0.2 | 2.0 | GO:0008272 | sulfate transport(GO:0008272) |
0.2 | 0.2 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.2 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 1.1 | GO:0043297 | apical junction assembly(GO:0043297) |
0.2 | 0.5 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.2 | 0.2 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.2 | 0.2 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.2 | 5.6 | GO:0050821 | protein stabilization(GO:0050821) |
0.2 | 0.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.2 | 0.4 | GO:0060438 | trachea development(GO:0060438) |
0.2 | 0.3 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
0.2 | 0.5 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.2 | 0.9 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.2 | 0.3 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.2 | 0.3 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.2 | 0.7 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.2 | 1.5 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.2 | 0.8 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.2 | 0.3 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.2 | 1.2 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.2 | 0.2 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.2 | 0.2 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.2 | 0.5 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 1.0 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 0.3 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.2 | 0.2 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.2 | 1.7 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 2.5 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.2 | 0.8 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.2 | 2.0 | GO:0034605 | cellular response to heat(GO:0034605) |
0.2 | 0.2 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 0.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 0.3 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.2 | 0.3 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.2 | 0.2 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.2 | 0.3 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.2 | 0.5 | GO:0032098 | regulation of appetite(GO:0032098) |
0.2 | 0.2 | GO:0042348 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.2 | 0.2 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.2 | 0.8 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.2 | 1.3 | GO:1904894 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
0.2 | 0.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.2 | 0.5 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.2 | 0.3 | GO:0033280 | response to vitamin D(GO:0033280) |
0.2 | 0.6 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.2 | 0.2 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 0.3 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.2 | 0.6 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.2 | 0.2 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.2 | 0.3 | GO:0001553 | luteinization(GO:0001553) |
0.2 | 0.2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.2 | 0.2 | GO:0010596 | negative regulation of endothelial cell migration(GO:0010596) |
0.2 | 1.2 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
0.2 | 0.2 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.2 | 0.2 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.1 | 0.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.7 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.3 | GO:0043144 | snoRNA processing(GO:0043144) |
0.1 | 1.0 | GO:0071173 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.1 | 0.1 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.1 | 0.7 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.1 | GO:0002246 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.1 | 0.1 | GO:0002118 | aggressive behavior(GO:0002118) |
0.1 | 0.1 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 0.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.9 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.1 | 0.3 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 2.5 | GO:0009988 | cell-cell recognition(GO:0009988) |
0.1 | 0.1 | GO:0039535 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039531) regulation of RIG-I signaling pathway(GO:0039535) |
0.1 | 1.7 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.1 | 1.0 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.3 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.1 | 0.1 | GO:0072198 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.1 | 0.5 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.3 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 2.6 | GO:0003341 | cilium movement(GO:0003341) |
0.1 | 0.1 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.7 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.1 | 0.1 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.1 | 0.1 | GO:0032252 | secretory granule localization(GO:0032252) |
0.1 | 0.4 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.9 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.1 | 4.9 | GO:0007051 | spindle organization(GO:0007051) |
0.1 | 1.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.3 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.1 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 1.0 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 1.7 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 0.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 1.9 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.1 | 0.3 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 1.5 | GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043280) |
0.1 | 0.1 | GO:0060914 | heart formation(GO:0060914) |
0.1 | 0.1 | GO:0009838 | abscission(GO:0009838) |
0.1 | 0.3 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.1 | 0.4 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.1 | GO:2000780 | negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
0.1 | 0.3 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.1 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.1 | 0.1 | GO:0061308 | cardiac neural crest cell differentiation involved in heart development(GO:0061307) cardiac neural crest cell development involved in heart development(GO:0061308) |
0.1 | 0.1 | GO:0044110 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
0.1 | 0.1 | GO:0072422 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.1 | 1.1 | GO:0001825 | blastocyst formation(GO:0001825) |
0.1 | 0.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 25.6 | GO:0007283 | spermatogenesis(GO:0007283) |
0.1 | 1.3 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.1 | 0.2 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.1 | 0.1 | GO:0097028 | dendritic cell differentiation(GO:0097028) |
0.1 | 0.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.1 | 0.6 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.3 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.1 | 0.2 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 0.3 | GO:0032720 | negative regulation of tumor necrosis factor production(GO:0032720) |
0.1 | 5.0 | GO:0006690 | icosanoid metabolic process(GO:0006690) fatty acid derivative metabolic process(GO:1901568) |
0.1 | 0.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.1 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
0.1 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.1 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.1 | 1.8 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.1 | 0.1 | GO:1901563 | response to camptothecin(GO:1901563) |
0.1 | 0.1 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.1 | 0.4 | GO:0030888 | regulation of B cell proliferation(GO:0030888) |
0.1 | 0.6 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.1 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 1.2 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.8 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 0.6 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.6 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.1 | 1.2 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 0.5 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.8 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.1 | 1.7 | GO:0007566 | embryo implantation(GO:0007566) |
0.1 | 0.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.1 | GO:0032633 | interleukin-4 production(GO:0032633) |
0.1 | 1.6 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
0.1 | 0.2 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.1 | 0.1 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.1 | 1.3 | GO:0031348 | negative regulation of defense response(GO:0031348) |
0.1 | 0.5 | GO:0044743 | intracellular protein transmembrane import(GO:0044743) |
0.1 | 2.0 | GO:0030509 | BMP signaling pathway(GO:0030509) |
0.1 | 0.1 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 0.1 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.6 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 0.1 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.1 | 0.1 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.1 | 0.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.1 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.1 | 0.2 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 5.6 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.1 | GO:0014009 | glial cell proliferation(GO:0014009) |
0.1 | 0.3 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 0.9 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
0.1 | 0.5 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.1 | 0.2 | GO:1901888 | regulation of cell junction assembly(GO:1901888) |
0.1 | 0.1 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 0.1 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.1 | 0.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.1 | GO:0033559 | unsaturated fatty acid metabolic process(GO:0033559) |
0.1 | 0.2 | GO:0007620 | copulation(GO:0007620) |
0.1 | 0.2 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.1 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.1 | 0.1 | GO:0061526 | acetylcholine secretion(GO:0061526) |
0.1 | 0.2 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
0.1 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.2 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.1 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
0.1 | 0.1 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 2.2 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 2.1 | GO:0044419 | symbiosis, encompassing mutualism through parasitism(GO:0044403) interspecies interaction between organisms(GO:0044419) |
0.1 | 0.1 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.1 | 0.1 | GO:0010453 | regulation of cell fate commitment(GO:0010453) |
0.1 | 0.1 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 0.1 | GO:0038031 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.2 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 1.5 | GO:0031497 | chromatin assembly(GO:0031497) |
0.1 | 0.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 0.3 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 0.2 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 0.1 | GO:0042772 | DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.1 | 0.2 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.3 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.1 | 0.1 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 0.2 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.1 | 0.3 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 0.1 | GO:0090031 | positive regulation of hormone metabolic process(GO:0032352) positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.1 | 0.1 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.1 | GO:0048048 | embryonic eye morphogenesis(GO:0048048) |
0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 4.5 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.1 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.1 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.1 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.1 | 0.8 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 0.1 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 0.1 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
0.1 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.5 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.1 | 0.1 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.9 | GO:0042476 | odontogenesis(GO:0042476) |
0.1 | 0.5 | GO:1903317 | regulation of protein maturation(GO:1903317) |
0.1 | 0.1 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.1 | 0.1 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.1 | GO:0002580 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) |
0.1 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 1.8 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.1 | 0.1 | GO:0070198 | protein localization to chromosome, telomeric region(GO:0070198) |
0.1 | 0.1 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.0 | 0.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.0 | 0.0 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.0 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.0 | 0.2 | GO:0045777 | positive regulation of blood pressure(GO:0045777) |
0.0 | 0.4 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.0 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
0.0 | 0.3 | GO:0051216 | cartilage development(GO:0051216) |
0.0 | 0.0 | GO:0032528 | microvillus organization(GO:0032528) |
0.0 | 0.0 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.1 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.0 | 0.0 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.0 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.0 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.0 | 0.0 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.0 | 0.3 | GO:0045582 | positive regulation of T cell differentiation(GO:0045582) |
0.0 | 0.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.0 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.0 | 0.4 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.0 | 0.4 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.0 | 39.8 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0060149 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by RNA(GO:0060967) |
0.0 | 0.1 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.1 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.0 | 0.0 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.0 | 0.1 | GO:1904970 | brush border assembly(GO:1904970) |
0.0 | 0.2 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.0 | 0.0 | GO:0035812 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.0 | 0.0 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.0 | 0.0 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.0 | 0.7 | GO:0048705 | skeletal system morphogenesis(GO:0048705) |
0.0 | 0.0 | GO:0090494 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.0 | 0.0 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) |
0.0 | 0.2 | GO:0001935 | endothelial cell proliferation(GO:0001935) |
0.0 | 0.0 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.0 | 0.0 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.0 | 0.0 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.0 | 0.0 | GO:0032663 | regulation of interleukin-2 production(GO:0032663) |
0.0 | 0.0 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.0 | 0.1 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.0 | 0.0 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.0 | 0.5 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 0.1 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.0 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.0 | 0.1 | GO:0003016 | respiratory system process(GO:0003016) |
0.0 | 0.0 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.0 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.0 | 0.0 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.0 | 0.1 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.0 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.6 | 38.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
6.2 | 18.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
6.0 | 12.0 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
5.0 | 29.8 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
4.7 | 14.0 | GO:0005588 | collagen type V trimer(GO:0005588) |
4.4 | 13.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
4.3 | 17.1 | GO:0071953 | elastic fiber(GO:0071953) |
4.3 | 12.8 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
3.8 | 11.5 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
3.8 | 30.4 | GO:0005861 | troponin complex(GO:0005861) |
3.6 | 10.9 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
3.2 | 12.8 | GO:0030478 | actin cap(GO:0030478) |
3.1 | 9.2 | GO:0005606 | laminin-1 complex(GO:0005606) |
3.0 | 9.1 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
3.0 | 15.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
3.0 | 12.1 | GO:0042583 | chromaffin granule(GO:0042583) |
3.0 | 30.0 | GO:0001527 | microfibril(GO:0001527) |
3.0 | 8.9 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
2.8 | 8.5 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
2.8 | 13.9 | GO:0030056 | hemidesmosome(GO:0030056) |
2.8 | 11.0 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
2.6 | 26.3 | GO:0098644 | complex of collagen trimers(GO:0098644) |
2.5 | 10.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
2.5 | 10.0 | GO:0000938 | GARP complex(GO:0000938) |
2.5 | 19.7 | GO:0043203 | axon hillock(GO:0043203) |
2.3 | 4.6 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
2.3 | 6.8 | GO:0005712 | chiasma(GO:0005712) |
2.2 | 13.4 | GO:0031983 | vesicle lumen(GO:0031983) |
2.2 | 4.4 | GO:0070820 | tertiary granule(GO:0070820) |
2.0 | 6.1 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
2.0 | 2.0 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
2.0 | 5.9 | GO:0032127 | dense core granule membrane(GO:0032127) |
1.9 | 17.4 | GO:0071439 | clathrin complex(GO:0071439) |
1.8 | 5.5 | GO:1990423 | RZZ complex(GO:1990423) |
1.8 | 7.3 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
1.8 | 5.5 | GO:0005594 | collagen type IX trimer(GO:0005594) |
1.8 | 107.0 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
1.8 | 106.7 | GO:0005581 | collagen trimer(GO:0005581) |
1.8 | 7.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.8 | 7.0 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.8 | 7.0 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
1.7 | 5.2 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
1.7 | 12.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
1.7 | 1.7 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
1.6 | 36.1 | GO:0008305 | integrin complex(GO:0008305) |
1.6 | 14.7 | GO:0097208 | alveolar lamellar body(GO:0097208) |
1.6 | 3.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
1.5 | 7.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
1.5 | 1.5 | GO:0000792 | heterochromatin(GO:0000792) |
1.5 | 6.1 | GO:0071203 | WASH complex(GO:0071203) |
1.5 | 15.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
1.5 | 3.0 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
1.5 | 4.5 | GO:0005927 | muscle tendon junction(GO:0005927) |
1.5 | 7.3 | GO:0005638 | lamin filament(GO:0005638) |
1.5 | 14.6 | GO:0035631 | CD40 receptor complex(GO:0035631) |
1.4 | 4.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.4 | 7.2 | GO:0005827 | polar microtubule(GO:0005827) |
1.4 | 1.4 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
1.4 | 5.7 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
1.4 | 2.8 | GO:0005914 | spot adherens junction(GO:0005914) |
1.4 | 1.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
1.4 | 2.8 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
1.4 | 2.7 | GO:0001739 | sex chromatin(GO:0001739) |
1.4 | 13.7 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
1.3 | 4.0 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
1.3 | 4.0 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
1.3 | 21.2 | GO:0043034 | costamere(GO:0043034) |
1.3 | 3.9 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
1.3 | 10.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
1.3 | 57.5 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
1.3 | 6.4 | GO:0070938 | contractile ring(GO:0070938) |
1.2 | 12.5 | GO:0031143 | pseudopodium(GO:0031143) |
1.2 | 2.4 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
1.2 | 90.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
1.2 | 12.2 | GO:0002102 | podosome(GO:0002102) |
1.2 | 9.7 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
1.2 | 2.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.2 | 12.9 | GO:0035102 | PRC1 complex(GO:0035102) |
1.1 | 5.7 | GO:0097255 | R2TP complex(GO:0097255) |
1.1 | 5.7 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
1.1 | 3.4 | GO:0044194 | cytolytic granule(GO:0044194) |
1.1 | 11.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
1.1 | 3.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.1 | 3.4 | GO:0097443 | sorting endosome(GO:0097443) |
1.1 | 10.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.1 | 6.7 | GO:0042641 | actomyosin(GO:0042641) |
1.1 | 6.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.1 | 4.4 | GO:0032591 | dendritic spine membrane(GO:0032591) |
1.1 | 4.3 | GO:1903349 | omegasome membrane(GO:1903349) |
1.1 | 6.4 | GO:0044327 | dendritic spine head(GO:0044327) |
1.1 | 5.3 | GO:0097422 | tubular endosome(GO:0097422) |
1.0 | 4.2 | GO:0005915 | zonula adherens(GO:0005915) |
1.0 | 4.2 | GO:0044326 | dendritic spine neck(GO:0044326) |
1.0 | 3.1 | GO:0097413 | Lewy body(GO:0097413) |
1.0 | 3.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
1.0 | 12.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
1.0 | 3.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
1.0 | 3.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
1.0 | 11.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.0 | 7.2 | GO:0016272 | prefoldin complex(GO:0016272) |
1.0 | 9.3 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
1.0 | 17.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
1.0 | 7.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.0 | 7.0 | GO:0005640 | nuclear outer membrane(GO:0005640) |
1.0 | 4.0 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
1.0 | 8.9 | GO:0000813 | ESCRT I complex(GO:0000813) |
1.0 | 6.9 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
1.0 | 3.0 | GO:0045298 | tubulin complex(GO:0045298) |
1.0 | 7.8 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
1.0 | 6.8 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
1.0 | 3.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.0 | 1.0 | GO:0032994 | protein-lipid complex(GO:0032994) |
1.0 | 266.6 | GO:0005925 | focal adhesion(GO:0005925) cell-substrate junction(GO:0030055) |
1.0 | 2.9 | GO:1990923 | PET complex(GO:1990923) |
0.9 | 8.5 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.9 | 4.7 | GO:0042629 | mast cell granule(GO:0042629) |
0.9 | 0.9 | GO:0000322 | storage vacuole(GO:0000322) |
0.9 | 1.9 | GO:0016939 | kinesin II complex(GO:0016939) |
0.9 | 6.4 | GO:0097542 | ciliary tip(GO:0097542) |
0.9 | 5.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.9 | 14.5 | GO:0097225 | sperm midpiece(GO:0097225) |
0.9 | 2.7 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.9 | 22.6 | GO:0031672 | A band(GO:0031672) |
0.9 | 15.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.9 | 56.3 | GO:0016363 | nuclear matrix(GO:0016363) |
0.9 | 0.9 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.9 | 5.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.9 | 5.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.9 | 7.9 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.9 | 4.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.9 | 2.6 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.9 | 14.5 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.9 | 8.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.9 | 2.6 | GO:0071942 | XPC complex(GO:0071942) |
0.8 | 0.8 | GO:0002142 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.8 | 10.1 | GO:0043218 | compact myelin(GO:0043218) |
0.8 | 32.4 | GO:0045095 | keratin filament(GO:0045095) |
0.8 | 3.3 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.8 | 17.7 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.8 | 2.4 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.8 | 40.6 | GO:0005811 | lipid particle(GO:0005811) |
0.8 | 8.7 | GO:0031011 | Ino80 complex(GO:0031011) |
0.8 | 1.5 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.8 | 3.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.8 | 4.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.8 | 1.5 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.8 | 0.8 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.8 | 6.0 | GO:0070652 | HAUS complex(GO:0070652) |
0.8 | 3.0 | GO:0032021 | NELF complex(GO:0032021) |
0.8 | 3.0 | GO:1990246 | uniplex complex(GO:1990246) |
0.7 | 22.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.7 | 0.7 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.7 | 8.8 | GO:0097440 | apical dendrite(GO:0097440) |
0.7 | 4.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.7 | 2.9 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.7 | 8.7 | GO:0031512 | motile primary cilium(GO:0031512) |
0.7 | 207.5 | GO:0031012 | extracellular matrix(GO:0031012) |
0.7 | 2.9 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.7 | 2.9 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.7 | 6.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.7 | 2.1 | GO:0032009 | early phagosome(GO:0032009) |
0.7 | 4.3 | GO:0097470 | ribbon synapse(GO:0097470) |
0.7 | 1.4 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.7 | 7.7 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.7 | 2.8 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.7 | 7.0 | GO:0031528 | microvillus membrane(GO:0031528) |
0.7 | 7.7 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.7 | 2.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.7 | 7.5 | GO:0030057 | desmosome(GO:0030057) |
0.7 | 10.3 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.7 | 0.7 | GO:0031523 | Myb complex(GO:0031523) |
0.7 | 121.7 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.7 | 2.7 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.7 | 2.7 | GO:0072487 | MSL complex(GO:0072487) |
0.7 | 3.4 | GO:0005916 | fascia adherens(GO:0005916) |
0.7 | 1.3 | GO:0044299 | C-fiber(GO:0044299) |
0.7 | 4.0 | GO:0045179 | apical cortex(GO:0045179) |
0.7 | 29.1 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.7 | 2.0 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.7 | 0.7 | GO:0030120 | vesicle coat(GO:0030120) |
0.7 | 2.0 | GO:0008091 | spectrin(GO:0008091) |
0.7 | 2.0 | GO:0000346 | transcription export complex(GO:0000346) |
0.7 | 1.3 | GO:0043219 | lateral loop(GO:0043219) |
0.6 | 3.8 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.6 | 0.6 | GO:0034464 | BBSome(GO:0034464) |
0.6 | 0.6 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.6 | 1.9 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.6 | 2.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.6 | 10.0 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.6 | 8.1 | GO:0000786 | nucleosome(GO:0000786) |
0.6 | 14.3 | GO:0005876 | spindle microtubule(GO:0005876) |
0.6 | 1.2 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.6 | 2.5 | GO:0061617 | MICOS complex(GO:0061617) |
0.6 | 2.5 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.6 | 2.4 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.6 | 37.8 | GO:0031674 | I band(GO:0031674) |
0.6 | 2.9 | GO:0002177 | manchette(GO:0002177) |
0.6 | 29.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.6 | 1.2 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.6 | 1.7 | GO:0005642 | annulate lamellae(GO:0005642) |
0.6 | 1.7 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.6 | 32.3 | GO:0005901 | caveola(GO:0005901) |
0.6 | 4.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.6 | 29.4 | GO:0016605 | PML body(GO:0016605) |
0.6 | 2.8 | GO:0089701 | U2AF(GO:0089701) |
0.6 | 2.8 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.6 | 0.6 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.6 | 2.2 | GO:0033063 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.5 | 0.5 | GO:0032437 | cuticular plate(GO:0032437) |
0.5 | 2.7 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.5 | 16.0 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.5 | 4.8 | GO:0030914 | STAGA complex(GO:0030914) |
0.5 | 0.5 | GO:0097452 | GAIT complex(GO:0097452) |
0.5 | 2.1 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.5 | 3.1 | GO:0090543 | Flemming body(GO:0090543) |
0.5 | 2.6 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.5 | 1.0 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.5 | 1.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.5 | 10.0 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.5 | 7.0 | GO:0000145 | exocyst(GO:0000145) |
0.5 | 8.9 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.5 | 2.5 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.5 | 2.0 | GO:0035339 | SPOTS complex(GO:0035339) |
0.5 | 3.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.5 | 26.6 | GO:0030496 | midbody(GO:0030496) |
0.5 | 1.0 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.5 | 1.0 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.5 | 1.9 | GO:0098536 | deuterosome(GO:0098536) |
0.5 | 1.9 | GO:0033270 | paranode region of axon(GO:0033270) |
0.5 | 3.8 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.5 | 3.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.5 | 0.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.5 | 34.7 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.5 | 4.7 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.5 | 1.9 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.5 | 1.9 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.5 | 1.4 | GO:0043296 | apical junction complex(GO:0043296) |
0.5 | 7.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.5 | 3.7 | GO:0014704 | intercalated disc(GO:0014704) |
0.5 | 0.9 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.5 | 14.8 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.5 | 2.3 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.5 | 4.6 | GO:0072686 | mitotic spindle(GO:0072686) |
0.5 | 1.8 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.5 | 2.7 | GO:0005688 | U6 snRNP(GO:0005688) |
0.5 | 5.9 | GO:0036038 | MKS complex(GO:0036038) |
0.5 | 5.4 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.5 | 6.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.5 | 9.0 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.4 | 1.8 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.4 | 104.6 | GO:0005667 | transcription factor complex(GO:0005667) |
0.4 | 1.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.4 | 5.8 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.4 | 2.7 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.4 | 0.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.4 | 4.0 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.4 | 14.5 | GO:0016592 | mediator complex(GO:0016592) |
0.4 | 1.3 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.4 | 3.9 | GO:0070852 | cell body fiber(GO:0070852) |
0.4 | 0.4 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.4 | 8.2 | GO:0016235 | aggresome(GO:0016235) |
0.4 | 3.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.4 | 4.3 | GO:0034706 | sodium channel complex(GO:0034706) |
0.4 | 0.4 | GO:0032432 | actin filament bundle(GO:0032432) |
0.4 | 3.0 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.4 | 22.1 | GO:0000922 | spindle pole(GO:0000922) |
0.4 | 3.8 | GO:0032797 | SMN complex(GO:0032797) |
0.4 | 0.4 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.4 | 3.4 | GO:0031902 | late endosome membrane(GO:0031902) |
0.4 | 0.4 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.4 | 3.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.4 | 1.7 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.4 | 2.5 | GO:0031209 | SCAR complex(GO:0031209) |
0.4 | 4.1 | GO:0005682 | U5 snRNP(GO:0005682) |
0.4 | 1.2 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.4 | 2.0 | GO:0070695 | FHF complex(GO:0070695) |
0.4 | 11.4 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.4 | 0.4 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.4 | 0.8 | GO:0000802 | transverse filament(GO:0000802) |
0.4 | 1.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.4 | 3.9 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.4 | 5.5 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.4 | 3.9 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.4 | 1.9 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.4 | 0.8 | GO:0042588 | zymogen granule(GO:0042588) |
0.4 | 3.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.4 | 1.9 | GO:0071986 | Ragulator complex(GO:0071986) |
0.4 | 0.8 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.4 | 11.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.4 | 0.4 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.4 | 1.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.4 | 0.4 | GO:0005686 | U2 snRNP(GO:0005686) |
0.4 | 1.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.4 | 7.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.4 | 4.1 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.4 | 1.9 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.4 | 0.7 | GO:0005839 | proteasome core complex(GO:0005839) |
0.4 | 1.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.4 | 2.9 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.4 | 6.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.4 | 1.4 | GO:0032982 | myosin filament(GO:0032982) |
0.4 | 1.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.4 | 0.7 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.4 | 14.4 | GO:0005643 | nuclear pore(GO:0005643) |
0.3 | 44.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.3 | 4.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 0.3 | GO:0005685 | U1 snRNP(GO:0005685) |
0.3 | 7.6 | GO:0015030 | Cajal body(GO:0015030) |
0.3 | 1.0 | GO:0001650 | fibrillar center(GO:0001650) |
0.3 | 2.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 1.7 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.3 | 0.7 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.3 | 10.3 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.3 | 2.0 | GO:0001520 | outer dense fiber(GO:0001520) |
0.3 | 7.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.3 | 0.3 | GO:0071010 | prespliceosome(GO:0071010) |
0.3 | 0.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.3 | 0.7 | GO:0071817 | MMXD complex(GO:0071817) |
0.3 | 23.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.3 | 1.3 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.3 | 2.6 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.3 | 0.3 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.3 | 0.3 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.3 | 0.3 | GO:0032280 | symmetric synapse(GO:0032280) |
0.3 | 197.5 | GO:0005615 | extracellular space(GO:0005615) |
0.3 | 0.3 | GO:1990635 | proximal dendrite(GO:1990635) |
0.3 | 4.0 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.3 | 2.4 | GO:0036156 | inner dynein arm(GO:0036156) |
0.3 | 0.9 | GO:0001741 | XY body(GO:0001741) |
0.3 | 2.7 | GO:0036128 | CatSper complex(GO:0036128) |
0.3 | 0.3 | GO:0005683 | U7 snRNP(GO:0005683) |
0.3 | 6.9 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.3 | 496.4 | GO:0070062 | extracellular exosome(GO:0070062) |
0.3 | 3.8 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.3 | 0.6 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.3 | 10.3 | GO:0005903 | brush border(GO:0005903) |
0.3 | 0.8 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.3 | 69.8 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.3 | 1.7 | GO:0071546 | pi-body(GO:0071546) |
0.3 | 0.8 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.3 | 1.6 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.3 | 0.8 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.3 | 0.3 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.3 | 2.9 | GO:0032039 | integrator complex(GO:0032039) |
0.3 | 0.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.3 | 0.3 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.3 | 0.5 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.3 | 0.8 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.3 | 1.0 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.3 | 1.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.3 | 4.6 | GO:0030016 | myofibril(GO:0030016) |
0.3 | 2.8 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.3 | 0.5 | GO:0016460 | myosin II complex(GO:0016460) |
0.2 | 0.5 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.2 | 5.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 2.7 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.2 | 8.6 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.2 | 60.3 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.2 | 1.9 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 4.9 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.2 | 0.7 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.2 | 206.5 | GO:0005654 | nucleoplasm(GO:0005654) |
0.2 | 0.2 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.2 | 1.8 | GO:0071012 | U2-type catalytic step 1 spliceosome(GO:0071006) catalytic step 1 spliceosome(GO:0071012) |
0.2 | 0.4 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.2 | 2.0 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.2 | 1.1 | GO:0060170 | ciliary membrane(GO:0060170) |
0.2 | 0.4 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.2 | 0.8 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 2.0 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.2 | 0.9 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 0.2 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.2 | 3.1 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 0.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.2 | 0.5 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.2 | 0.2 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.2 | 0.2 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.2 | 0.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 2.8 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 0.7 | GO:1990391 | DNA repair complex(GO:1990391) |
0.2 | 2.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 0.5 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.2 | 0.3 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 0.6 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 0.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 9.0 | GO:0045177 | apical part of cell(GO:0045177) |
0.2 | 0.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.3 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.1 | 14.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 67.4 | GO:0005576 | extracellular region(GO:0005576) |
0.1 | 0.9 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.7 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.1 | 0.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.5 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 0.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.8 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 2.0 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 0.8 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 1.1 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.1 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 0.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 3.1 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.1 | 0.2 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.1 | 0.3 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.2 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 0.1 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.3 | GO:0042825 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.1 | 3.7 | GO:0097223 | sperm part(GO:0097223) |
0.1 | 0.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.1 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 0.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 8.0 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 2.2 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.3 | GO:0000801 | central element(GO:0000801) |
0.1 | 1.2 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 0.8 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 0.2 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.4 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.3 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.2 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.0 | 0.0 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.0 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 1.9 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.1 | GO:0043292 | contractile fiber(GO:0043292) |
0.0 | 1.3 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.1 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.1 | GO:0005819 | spindle(GO:0005819) |
0.0 | 0.0 | GO:0035838 | growing cell tip(GO:0035838) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.7 | 20.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
6.0 | 24.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
5.8 | 70.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
5.6 | 44.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
5.3 | 15.9 | GO:0070538 | oleic acid binding(GO:0070538) |
5.3 | 21.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
4.8 | 14.4 | GO:0035939 | microsatellite binding(GO:0035939) |
4.5 | 27.1 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
4.4 | 17.5 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
4.2 | 12.7 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
3.8 | 11.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
3.7 | 11.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
3.6 | 35.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
3.6 | 14.2 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
3.5 | 14.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
3.5 | 17.5 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
3.4 | 17.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
3.4 | 24.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
3.3 | 10.0 | GO:0031014 | troponin T binding(GO:0031014) |
3.3 | 30.0 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
3.3 | 13.1 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
3.2 | 12.8 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
3.2 | 12.8 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
3.2 | 9.5 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
3.2 | 19.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
3.0 | 12.2 | GO:0015265 | urea channel activity(GO:0015265) |
2.9 | 5.8 | GO:0019959 | interleukin-8 binding(GO:0019959) |
2.9 | 14.4 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
2.7 | 8.2 | GO:0030172 | troponin C binding(GO:0030172) |
2.7 | 21.7 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
2.7 | 8.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
2.6 | 13.0 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
2.6 | 26.0 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
2.5 | 7.6 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
2.5 | 15.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
2.5 | 7.5 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
2.5 | 12.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
2.5 | 17.3 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
2.4 | 9.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
2.4 | 12.0 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
2.4 | 43.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
2.4 | 7.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
2.4 | 16.5 | GO:0018644 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
2.3 | 9.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
2.3 | 6.8 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
2.3 | 13.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
2.2 | 6.6 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
2.2 | 2.2 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
2.1 | 8.5 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
2.1 | 6.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
2.1 | 2.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
2.1 | 8.4 | GO:0061665 | SUMO ligase activity(GO:0061665) |
2.0 | 5.9 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
2.0 | 5.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.9 | 11.7 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
1.9 | 7.7 | GO:0042731 | PH domain binding(GO:0042731) |
1.9 | 5.8 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
1.9 | 24.5 | GO:0001968 | fibronectin binding(GO:0001968) |
1.9 | 5.6 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.9 | 28.1 | GO:0005003 | ephrin receptor activity(GO:0005003) |
1.9 | 13.0 | GO:0048406 | nerve growth factor binding(GO:0048406) |
1.8 | 5.5 | GO:0038181 | bile acid receptor activity(GO:0038181) |
1.8 | 9.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
1.8 | 7.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.8 | 12.6 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
1.8 | 5.4 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
1.8 | 9.0 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
1.7 | 5.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
1.7 | 22.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
1.7 | 1.7 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
1.7 | 5.1 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
1.7 | 20.4 | GO:0017166 | vinculin binding(GO:0017166) |
1.7 | 6.7 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
1.7 | 6.6 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.6 | 11.5 | GO:0070492 | oligosaccharide binding(GO:0070492) |
1.6 | 8.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.6 | 6.5 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
1.6 | 24.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
1.6 | 4.8 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.6 | 1.6 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
1.6 | 4.7 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.6 | 4.7 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
1.6 | 7.8 | GO:0070061 | fructose binding(GO:0070061) |
1.6 | 3.1 | GO:0038132 | neuregulin binding(GO:0038132) |
1.5 | 3.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
1.5 | 10.7 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
1.5 | 4.6 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
1.5 | 1.5 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
1.5 | 6.0 | GO:0019237 | centromeric DNA binding(GO:0019237) |
1.5 | 4.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.5 | 81.9 | GO:0005518 | collagen binding(GO:0005518) |
1.5 | 1.5 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
1.5 | 10.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.5 | 4.4 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
1.5 | 13.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
1.5 | 4.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
1.5 | 13.1 | GO:0004017 | adenylate kinase activity(GO:0004017) |
1.4 | 2.9 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
1.4 | 10.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
1.4 | 4.3 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.4 | 2.9 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
1.4 | 2.8 | GO:0004096 | catalase activity(GO:0004096) |
1.4 | 2.8 | GO:0016419 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
1.4 | 4.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
1.4 | 14.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
1.4 | 4.2 | GO:0038100 | nodal binding(GO:0038100) |
1.4 | 2.8 | GO:0015928 | fucosidase activity(GO:0015928) |
1.4 | 4.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
1.4 | 4.1 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
1.4 | 1.4 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
1.4 | 10.9 | GO:0008430 | selenium binding(GO:0008430) |
1.3 | 4.0 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
1.3 | 12.1 | GO:0001222 | transcription corepressor binding(GO:0001222) |
1.3 | 28.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
1.3 | 12.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
1.3 | 14.7 | GO:0044548 | S100 protein binding(GO:0044548) |
1.3 | 4.0 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
1.3 | 4.0 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
1.3 | 15.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
1.3 | 2.6 | GO:0070698 | type I activin receptor binding(GO:0070698) |
1.3 | 5.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.3 | 3.9 | GO:0055100 | adiponectin binding(GO:0055100) |
1.3 | 5.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.3 | 3.9 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
1.3 | 3.9 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
1.3 | 3.8 | GO:1990715 | mRNA CDS binding(GO:1990715) |
1.3 | 28.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
1.3 | 3.8 | GO:1990188 | euchromatin binding(GO:1990188) |
1.3 | 3.8 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.3 | 1.3 | GO:0071253 | connexin binding(GO:0071253) |
1.3 | 3.8 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
1.3 | 2.5 | GO:0050692 | DBD domain binding(GO:0050692) |
1.2 | 39.8 | GO:0070888 | E-box binding(GO:0070888) |
1.2 | 12.4 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
1.2 | 3.7 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.2 | 6.2 | GO:0008312 | 7S RNA binding(GO:0008312) |
1.2 | 4.9 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
1.2 | 3.7 | GO:0004461 | lactose synthase activity(GO:0004461) |
1.2 | 14.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
1.2 | 3.7 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
1.2 | 20.5 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
1.2 | 2.4 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
1.2 | 2.4 | GO:0043842 | Kdo transferase activity(GO:0043842) |
1.2 | 6.0 | GO:0030274 | LIM domain binding(GO:0030274) |
1.2 | 2.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
1.2 | 6.0 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
1.2 | 10.6 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
1.2 | 2.4 | GO:0004771 | sterol esterase activity(GO:0004771) |
1.2 | 8.2 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
1.2 | 10.5 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
1.2 | 7.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
1.2 | 7.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
1.2 | 5.8 | GO:0045545 | syndecan binding(GO:0045545) |
1.1 | 2.3 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
1.1 | 11.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
1.1 | 10.0 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
1.1 | 6.7 | GO:0015197 | peptide transporter activity(GO:0015197) |
1.1 | 3.3 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.1 | 2.2 | GO:0045503 | dynein light chain binding(GO:0045503) |
1.1 | 12.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
1.1 | 9.8 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
1.1 | 1.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
1.1 | 8.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.1 | 4.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.1 | 5.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
1.1 | 6.4 | GO:0043910 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
1.1 | 11.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
1.1 | 3.2 | GO:0070411 | I-SMAD binding(GO:0070411) |
1.1 | 5.3 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
1.1 | 1.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.1 | 1.1 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
1.1 | 5.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
1.0 | 70.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
1.0 | 32.2 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
1.0 | 2.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
1.0 | 91.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
1.0 | 13.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
1.0 | 68.9 | GO:0005178 | integrin binding(GO:0005178) |
1.0 | 2.0 | GO:0015205 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
1.0 | 4.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
1.0 | 3.1 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
1.0 | 9.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
1.0 | 3.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.0 | 45.2 | GO:0035064 | methylated histone binding(GO:0035064) |
1.0 | 5.0 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
1.0 | 4.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
1.0 | 3.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
1.0 | 17.0 | GO:0003785 | actin monomer binding(GO:0003785) |
1.0 | 5.0 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
1.0 | 2.0 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
1.0 | 3.9 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
1.0 | 3.9 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
1.0 | 2.0 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
1.0 | 2.0 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
1.0 | 2.9 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.0 | 1.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
1.0 | 1.0 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
1.0 | 7.7 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
1.0 | 6.7 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
1.0 | 2.9 | GO:0036033 | mediator complex binding(GO:0036033) |
0.9 | 20.9 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.9 | 4.7 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.9 | 6.6 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.9 | 1.9 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.9 | 2.8 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.9 | 0.9 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.9 | 4.7 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.9 | 19.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.9 | 3.7 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.9 | 4.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.9 | 3.7 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.9 | 4.6 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.9 | 2.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.9 | 3.6 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.9 | 30.8 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.9 | 9.9 | GO:0016208 | AMP binding(GO:0016208) |
0.9 | 3.6 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.9 | 9.9 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.9 | 3.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.9 | 5.3 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.9 | 12.4 | GO:0005521 | lamin binding(GO:0005521) |
0.9 | 12.4 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.9 | 0.9 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.9 | 12.3 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.9 | 7.9 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.9 | 9.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.9 | 4.4 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.9 | 0.9 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.9 | 2.6 | GO:2001070 | starch binding(GO:2001070) |
0.9 | 4.3 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.9 | 2.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.9 | 9.5 | GO:0034843 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.9 | 2.6 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.9 | 3.5 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.9 | 4.3 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.9 | 1.7 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.8 | 4.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.8 | 4.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.8 | 8.4 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.8 | 1.7 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.8 | 1.7 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.8 | 2.5 | GO:0070840 | dynein complex binding(GO:0070840) |
0.8 | 6.7 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.8 | 15.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.8 | 15.0 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.8 | 26.4 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.8 | 5.8 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.8 | 5.8 | GO:0038191 | neuropilin binding(GO:0038191) |
0.8 | 23.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.8 | 3.3 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.8 | 9.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.8 | 22.1 | GO:0045182 | translation regulator activity(GO:0045182) |
0.8 | 26.2 | GO:0018732 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.8 | 3.3 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.8 | 7.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.8 | 3.2 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.8 | 4.8 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.8 | 4.8 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.8 | 28.1 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.8 | 3.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.8 | 1.6 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.8 | 4.0 | GO:0070728 | leucine binding(GO:0070728) |
0.8 | 4.0 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.8 | 8.6 | GO:0015643 | toxic substance binding(GO:0015643) |
0.8 | 21.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.8 | 3.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.8 | 1.6 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.8 | 1.5 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.8 | 2.3 | GO:0051380 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
0.8 | 0.8 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) thiol oxidase activity(GO:0016972) |
0.8 | 8.4 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.8 | 0.8 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.8 | 7.6 | GO:0008143 | poly(A) binding(GO:0008143) |
0.8 | 9.8 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.8 | 15.0 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.7 | 3.7 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.7 | 3.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.7 | 4.5 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.7 | 2.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.7 | 15.6 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.7 | 3.0 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.7 | 34.1 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.7 | 2.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.7 | 17.7 | GO:0042805 | actinin binding(GO:0042805) |
0.7 | 2.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.7 | 2.2 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.7 | 5.1 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.7 | 4.4 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.7 | 5.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.7 | 2.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.7 | 1.4 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.7 | 1.4 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.7 | 12.2 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.7 | 3.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.7 | 2.9 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.7 | 16.4 | GO:0030515 | snoRNA binding(GO:0030515) |
0.7 | 2.9 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.7 | 2.1 | GO:0034827 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.7 | 6.4 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.7 | 2.8 | GO:0005499 | vitamin D binding(GO:0005499) |
0.7 | 3.5 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.7 | 2.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.7 | 3.5 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.7 | 2.1 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.7 | 0.7 | GO:0016748 | succinyltransferase activity(GO:0016748) S-succinyltransferase activity(GO:0016751) |
0.7 | 4.2 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.7 | 1.4 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.7 | 2.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.7 | 0.7 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.7 | 3.4 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.7 | 7.6 | GO:0016918 | retinal binding(GO:0016918) |
0.7 | 2.1 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.7 | 2.7 | GO:0034584 | piRNA binding(GO:0034584) |
0.7 | 4.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.7 | 2.1 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.7 | 0.7 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.7 | 1.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.7 | 25.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.7 | 0.7 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.7 | 1.3 | GO:0035276 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) ethanol binding(GO:0035276) |
0.7 | 6.0 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.7 | 1.3 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.7 | 4.6 | GO:0031996 | thioesterase binding(GO:0031996) |
0.7 | 10.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.7 | 4.6 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.7 | 2.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.7 | 10.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.7 | 1.3 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.6 | 1.9 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.6 | 9.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.6 | 20.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.6 | 1.3 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.6 | 0.6 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.6 | 3.2 | GO:0016936 | galactoside binding(GO:0016936) |
0.6 | 0.6 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.6 | 1.9 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.6 | 1.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.6 | 1.3 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.6 | 7.0 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.6 | 4.4 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.6 | 2.5 | GO:0034452 | dynactin binding(GO:0034452) |
0.6 | 0.6 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.6 | 7.4 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.6 | 7.4 | GO:0030275 | LRR domain binding(GO:0030275) |
0.6 | 6.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.6 | 9.2 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.6 | 11.0 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.6 | 1.2 | GO:0031432 | titin binding(GO:0031432) |
0.6 | 17.0 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.6 | 0.6 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.6 | 1.8 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.6 | 5.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.6 | 1.8 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.6 | 3.6 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.6 | 3.6 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.6 | 4.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.6 | 1.8 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.6 | 1.8 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.6 | 1.8 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.6 | 8.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.6 | 5.9 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.6 | 2.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.6 | 0.6 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.6 | 5.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.6 | 1.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.6 | 3.5 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.6 | 62.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.6 | 2.3 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.6 | 0.6 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.6 | 1.1 | GO:0008199 | ferric iron binding(GO:0008199) |
0.6 | 3.4 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.6 | 2.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.6 | 1.7 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.6 | 1.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.6 | 1.7 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.6 | 7.9 | GO:0002039 | p53 binding(GO:0002039) |
0.6 | 0.6 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.6 | 1.1 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.6 | 2.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.6 | 1.1 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.6 | 2.2 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.6 | 1.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.6 | 6.7 | GO:0015026 | coreceptor activity(GO:0015026) |
0.6 | 6.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.5 | 6.0 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.5 | 2.7 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.5 | 1.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.5 | 7.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.5 | 0.5 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.5 | 8.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.5 | 1.6 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.5 | 6.5 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.5 | 1.1 | GO:0005534 | galactose binding(GO:0005534) |
0.5 | 2.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.5 | 3.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.5 | 10.7 | GO:0043531 | ADP binding(GO:0043531) |
0.5 | 5.3 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.5 | 2.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.5 | 4.8 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.5 | 1.1 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.5 | 1.6 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.5 | 1.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.5 | 2.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.5 | 4.2 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.5 | 20.9 | GO:0017022 | myosin binding(GO:0017022) |
0.5 | 1.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.5 | 1.6 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.5 | 3.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.5 | 5.7 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.5 | 1.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.5 | 3.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.5 | 1.0 | GO:0031433 | telethonin binding(GO:0031433) |
0.5 | 19.6 | GO:0019838 | growth factor binding(GO:0019838) |
0.5 | 9.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.5 | 4.6 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.5 | 2.0 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.5 | 6.6 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.5 | 1.0 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.5 | 2.0 | GO:0043829 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.5 | 1.5 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.5 | 8.0 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.5 | 2.5 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.5 | 1.5 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.5 | 1.5 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.5 | 3.9 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.5 | 1.0 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.5 | 3.4 | GO:0071949 | FAD binding(GO:0071949) |
0.5 | 3.9 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.5 | 1.5 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.5 | 2.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.5 | 0.5 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.5 | 3.9 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.5 | 1.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.5 | 1.0 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.5 | 0.5 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.5 | 3.8 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.5 | 1.4 | GO:0035198 | miRNA binding(GO:0035198) |
0.5 | 0.9 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.5 | 3.3 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.5 | 10.3 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.5 | 4.2 | GO:0034871 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.5 | 85.6 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.5 | 7.0 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.5 | 1.4 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.5 | 0.9 | GO:0050733 | RS domain binding(GO:0050733) |
0.5 | 0.5 | GO:0034618 | arginine binding(GO:0034618) |
0.5 | 13.8 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.5 | 6.0 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.5 | 3.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.5 | 2.7 | GO:0005536 | glucose binding(GO:0005536) |
0.5 | 4.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.5 | 3.6 | GO:0070513 | death domain binding(GO:0070513) |
0.5 | 2.3 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.5 | 2.7 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.5 | 1.8 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.5 | 2.3 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.4 | 2.2 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.4 | 1.3 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.4 | 2.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.4 | 1.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.4 | 1.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.4 | 33.5 | GO:0051015 | actin filament binding(GO:0051015) |
0.4 | 2.7 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.4 | 3.1 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.4 | 2.2 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.4 | 1.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.4 | 5.7 | GO:0015145 | monosaccharide transmembrane transporter activity(GO:0015145) |
0.4 | 1.7 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.4 | 3.9 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.4 | 1.7 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.4 | 0.9 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.4 | 3.0 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.4 | 0.9 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.4 | 1.3 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.4 | 1.7 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.4 | 25.4 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.4 | 1.3 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.4 | 4.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.4 | 0.8 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.4 | 1.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.4 | 35.5 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.4 | 3.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.4 | 10.0 | GO:0035410 | dihydrotestosterone 17-beta-dehydrogenase activity(GO:0035410) |
0.4 | 3.8 | GO:0003796 | lysozyme activity(GO:0003796) |
0.4 | 1.2 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.4 | 1.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.4 | 4.9 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.4 | 2.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.4 | 2.9 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.4 | 0.8 | GO:0008933 | lytic transglycosylase activity(GO:0008933) |
0.4 | 0.4 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.4 | 1.6 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.4 | 14.6 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.4 | 3.6 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.4 | 2.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.4 | 0.8 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.4 | 13.7 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.4 | 1.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.4 | 0.8 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.4 | 1.2 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.4 | 1.6 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.4 | 0.4 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.4 | 0.4 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.4 | 1.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.4 | 1.6 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.4 | 4.3 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.4 | 0.4 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.4 | 0.4 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.4 | 2.3 | GO:0000339 | RNA cap binding(GO:0000339) |
0.4 | 0.4 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.4 | 7.7 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.4 | 6.5 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.4 | 8.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.4 | 1.1 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.4 | 0.4 | GO:1990254 | keratin filament binding(GO:1990254) |
0.4 | 11.3 | GO:0043621 | protein self-association(GO:0043621) |
0.4 | 2.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.4 | 9.0 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.4 | 5.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.4 | 50.8 | GO:0061659 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.4 | 1.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.4 | 1.8 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.4 | 2.2 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.4 | 1.5 | GO:0015232 | heme transporter activity(GO:0015232) |
0.4 | 1.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.4 | 1.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.4 | 2.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.4 | 5.8 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.4 | 0.4 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.4 | 0.4 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.4 | 0.4 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.4 | 1.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.4 | 0.4 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.4 | 0.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.4 | 0.7 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.4 | 1.1 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.4 | 1.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.3 | 10.1 | GO:0001047 | core promoter binding(GO:0001047) |
0.3 | 0.7 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.3 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.3 | 1.4 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.3 | 1.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.3 | 1.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.3 | 1.7 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.3 | 2.4 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.3 | 2.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.3 | 2.0 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.3 | 0.3 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) |
0.3 | 5.6 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.3 | 8.6 | GO:0030145 | manganese ion binding(GO:0030145) |
0.3 | 0.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.3 | 1.3 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.3 | 47.1 | GO:0003779 | actin binding(GO:0003779) |
0.3 | 1.0 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.3 | 2.3 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.3 | 5.5 | GO:0002020 | protease binding(GO:0002020) |
0.3 | 1.0 | GO:0035197 | siRNA binding(GO:0035197) |
0.3 | 1.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.3 | 1.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.3 | 0.3 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.3 | 0.3 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.3 | 0.9 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.3 | 1.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.3 | 3.1 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.3 | 0.3 | GO:0035173 | histone kinase activity(GO:0035173) |
0.3 | 1.6 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.3 | 16.7 | GO:0005506 | iron ion binding(GO:0005506) |
0.3 | 0.3 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.3 | 1.8 | GO:0048038 | quinone binding(GO:0048038) |
0.3 | 14.0 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
0.3 | 0.9 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.3 | 0.6 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.3 | 1.8 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.3 | 0.9 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.3 | 0.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.3 | 0.3 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.3 | 3.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.3 | 0.3 | GO:0002134 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.3 | 3.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.3 | 0.6 | GO:0050051 | alkane 1-monooxygenase activity(GO:0018685) leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.3 | 4.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 8.4 | GO:0042393 | histone binding(GO:0042393) |
0.3 | 0.3 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.3 | 0.3 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.3 | 0.3 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.3 | 2.9 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.3 | 0.6 | GO:0019002 | GMP binding(GO:0019002) |
0.3 | 0.9 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.3 | 0.6 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.3 | 0.9 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.3 | 0.9 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.3 | 118.9 | GO:0005198 | structural molecule activity(GO:0005198) |
0.3 | 1.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.3 | 0.6 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.3 | 2.8 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.3 | 5.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.3 | 19.8 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.3 | 5.8 | GO:0015485 | cholesterol binding(GO:0015485) |
0.3 | 0.3 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.3 | 1.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.3 | 69.6 | GO:0003682 | chromatin binding(GO:0003682) |
0.3 | 1.4 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.3 | 2.5 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.3 | 0.8 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.3 | 2.7 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.3 | 0.5 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.3 | 0.3 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.3 | 3.4 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.3 | 4.2 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.3 | 39.4 | GO:0005125 | cytokine activity(GO:0005125) |
0.3 | 0.8 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.3 | 0.8 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.2 | 0.5 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 2.0 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 0.2 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 0.7 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 5.7 | GO:0005507 | copper ion binding(GO:0005507) |
0.2 | 1.7 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.2 | 2.5 | GO:0008061 | chitin binding(GO:0008061) |
0.2 | 1.0 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 1.7 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 1.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 0.7 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.2 | 0.5 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.2 | 0.2 | GO:0032934 | sterol binding(GO:0032934) |
0.2 | 0.9 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.2 | 0.2 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) |
0.2 | 3.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 1.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 0.7 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.2 | 0.7 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.2 | 1.8 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 2.2 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.2 | 0.7 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.2 | 1.8 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 2.9 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.2 | 0.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 0.4 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 2.0 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.2 | 1.9 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.2 | 1.3 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.2 | 0.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.2 | 32.4 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.2 | 1.5 | GO:0015266 | protein channel activity(GO:0015266) |
0.2 | 0.4 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.2 | 2.1 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 3.0 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.2 | 26.5 | GO:0004857 | enzyme inhibitor activity(GO:0004857) |
0.2 | 14.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.2 | 2.7 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.2 | 0.6 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.2 | 4.1 | GO:0000049 | tRNA binding(GO:0000049) |
0.2 | 4.3 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.2 | 0.2 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.2 | 0.8 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.2 | 0.6 | GO:0002046 | opsin binding(GO:0002046) |
0.2 | 3.4 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.2 | 13.3 | GO:0003774 | motor activity(GO:0003774) |
0.2 | 7.6 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 0.8 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.2 | 15.9 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.2 | 0.4 | GO:0051861 | glycolipid binding(GO:0051861) |
0.2 | 0.9 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 0.4 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.2 | 0.9 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.2 | 2.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 1.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 0.5 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.2 | 7.9 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.2 | 6.7 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.2 | 0.7 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 0.5 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 8.0 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.2 | 0.5 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.2 | 0.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 0.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 2.9 | GO:0005186 | pheromone activity(GO:0005186) |
0.2 | 0.3 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.2 | 7.7 | GO:0008201 | heparin binding(GO:0008201) |
0.2 | 0.8 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 3.0 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.2 | 0.6 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 0.2 | GO:0042887 | amide transmembrane transporter activity(GO:0042887) |
0.2 | 2.7 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.2 | 14.5 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.2 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.5 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.2 | 0.3 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 0.5 | GO:0004359 | glutaminase activity(GO:0004359) |
0.2 | 0.2 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.2 | 0.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.2 | 0.3 | GO:0019862 | IgA binding(GO:0019862) |
0.2 | 0.8 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 0.2 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.2 | 0.9 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 2.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 1.0 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.4 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.1 | 0.9 | GO:0019798 | procollagen-proline dioxygenase activity(GO:0019798) |
0.1 | 0.6 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.1 | 0.3 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.1 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.1 | 0.1 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.5 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 0.1 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.1 | 0.5 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.1 | 0.6 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 0.4 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.5 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.5 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.4 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
0.1 | 0.1 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.1 | 2.3 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 1.6 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.1 | 0.2 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.1 | 0.1 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.1 | 0.3 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.1 | 0.3 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.1 | 0.9 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 3.6 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.1 | 0.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 1.4 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.8 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.1 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 0.2 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 0.1 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.3 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 9.0 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 1.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.2 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.1 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 3.6 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 0.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.7 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.1 | 0.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 14.2 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 5.3 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.1 | 0.1 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 1.3 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.5 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.1 | 0.2 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 2.1 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 0.3 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.1 | 0.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.2 | GO:0016405 | CoA-ligase activity(GO:0016405) |
0.1 | 3.0 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 0.1 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.1 | 0.2 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 0.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 0.1 | GO:0016803 | hydrolase activity, acting on ether bonds(GO:0016801) ether hydrolase activity(GO:0016803) |
0.1 | 16.6 | GO:0008270 | zinc ion binding(GO:0008270) |
0.1 | 0.5 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.7 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 2.4 | GO:0001664 | G-protein coupled receptor binding(GO:0001664) |
0.1 | 0.8 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.4 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 1.3 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
0.1 | 0.1 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.1 | 0.3 | GO:0015250 | water channel activity(GO:0015250) |
0.1 | 0.3 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.1 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 0.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.4 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.0 | 0.6 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.0 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.0 | 0.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.0 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.0 | 0.1 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.0 | 34.6 | GO:0003677 | DNA binding(GO:0003677) |
0.0 | 0.9 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.0 | 42.6 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 2.7 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.0 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 0.6 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 2.8 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 1.0 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.5 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.1 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.0 | 0.0 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.0 | 0.0 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 0.2 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.0 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.2 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.1 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.0 | 0.0 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.0 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.0 | 0.1 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.0 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.0 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.0 | 0.0 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.4 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.0 | 0.0 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.0 | GO:0035870 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.4 | 10.8 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
4.3 | 4.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
3.5 | 148.6 | NABA COLLAGENS | Genes encoding collagen proteins |
2.9 | 2.9 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
2.1 | 65.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
2.0 | 53.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
1.9 | 44.4 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
1.9 | 59.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
1.9 | 28.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
1.9 | 83.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
1.9 | 5.6 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
1.9 | 37.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
1.8 | 7.4 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
1.8 | 20.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
1.8 | 5.5 | PID ALK2 PATHWAY | ALK2 signaling events |
1.7 | 34.7 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
1.5 | 16.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
1.5 | 3.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
1.5 | 40.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
1.5 | 25.4 | PID IGF1 PATHWAY | IGF1 pathway |
1.5 | 32.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
1.4 | 27.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
1.4 | 29.8 | PID IL3 PATHWAY | IL3-mediated signaling events |
1.4 | 11.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.3 | 20.2 | PID S1P S1P3 PATHWAY | S1P3 pathway |
1.3 | 37.5 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
1.3 | 1.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
1.2 | 42.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
1.2 | 22.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
1.2 | 13.6 | PID EPO PATHWAY | EPO signaling pathway |
1.2 | 15.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
1.2 | 16.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
1.2 | 8.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.2 | 174.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
1.1 | 6.9 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.1 | 1.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
1.1 | 6.6 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
1.0 | 18.4 | PID AURORA A PATHWAY | Aurora A signaling |
1.0 | 61.1 | PID CMYB PATHWAY | C-MYB transcription factor network |
1.0 | 24.0 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
1.0 | 37.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.9 | 9.4 | PID ENDOTHELIN PATHWAY | Endothelins |
0.9 | 11.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.9 | 3.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.9 | 5.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.9 | 16.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.9 | 5.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.8 | 27.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.8 | 11.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.8 | 2.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.8 | 6.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.8 | 21.2 | PID AURORA B PATHWAY | Aurora B signaling |
0.8 | 10.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.7 | 12.0 | PID BMP PATHWAY | BMP receptor signaling |
0.7 | 5.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.7 | 32.0 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.7 | 97.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.7 | 15.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.7 | 18.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.7 | 13.7 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.7 | 3.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.7 | 10.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.7 | 4.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.7 | 6.9 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.7 | 12.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.7 | 2.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.7 | 17.0 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.7 | 6.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.7 | 0.7 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.7 | 17.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.7 | 5.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.7 | 2.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.7 | 11.7 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.6 | 6.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.6 | 7.7 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.6 | 5.7 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.6 | 10.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.6 | 8.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.6 | 18.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.6 | 1.9 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.6 | 2.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.6 | 4.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.6 | 119.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.6 | 1.8 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.6 | 8.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.6 | 19.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.6 | 8.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.6 | 22.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.6 | 3.9 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.6 | 7.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.5 | 8.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.5 | 12.9 | PID P73PATHWAY | p73 transcription factor network |
0.5 | 120.1 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.5 | 17.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.5 | 7.1 | PID BARD1 PATHWAY | BARD1 signaling events |
0.5 | 3.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.5 | 1.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.5 | 1.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.5 | 2.8 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.5 | 6.5 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.5 | 6.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.5 | 4.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.4 | 8.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.4 | 3.0 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.4 | 3.8 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.4 | 13.0 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.4 | 5.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.4 | 17.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.4 | 4.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.4 | 2.9 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.4 | 1.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.4 | 18.0 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.4 | 2.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.3 | 1.4 | PID IFNG PATHWAY | IFN-gamma pathway |
0.3 | 8.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.3 | 0.6 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.3 | 1.6 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.3 | 3.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.3 | 5.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 4.2 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.3 | 5.3 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.3 | 9.1 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.3 | 2.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.3 | 0.5 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.3 | 0.3 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.3 | 3.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 0.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 4.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 2.0 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 0.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 1.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 2.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 3.1 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 0.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 1.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 0.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 0.6 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 0.5 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 0.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 0.2 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 0.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 1.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 2.3 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 1.5 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 0.7 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 1.2 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 1.5 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.6 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 0.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.7 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.9 | PID ATM PATHWAY | ATM pathway |
0.1 | 1.8 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 1.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 0.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.5 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 61.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
3.3 | 55.5 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
3.1 | 162.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
2.8 | 22.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
2.8 | 11.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
2.7 | 32.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
2.6 | 26.2 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
2.4 | 63.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
2.3 | 4.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
2.3 | 2.3 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
2.2 | 6.7 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
2.1 | 14.8 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
2.1 | 18.7 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
2.0 | 26.4 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
1.8 | 1.8 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
1.8 | 17.8 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
1.8 | 24.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
1.7 | 12.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
1.7 | 27.6 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
1.7 | 21.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
1.6 | 24.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
1.5 | 15.5 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
1.4 | 29.7 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
1.4 | 15.4 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
1.4 | 7.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.4 | 15.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
1.4 | 10.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
1.3 | 8.0 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
1.3 | 19.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.3 | 8.8 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
1.2 | 12.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
1.2 | 3.7 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
1.2 | 86.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
1.2 | 23.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
1.2 | 50.4 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
1.1 | 60.7 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
1.1 | 17.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.1 | 1.1 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
1.1 | 10.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.1 | 1.1 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
1.1 | 1.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
1.1 | 29.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
1.1 | 9.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
1.1 | 1.1 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
1.0 | 11.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.0 | 16.2 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
1.0 | 4.0 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
1.0 | 1.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
1.0 | 21.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
1.0 | 10.7 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
1.0 | 9.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
1.0 | 1.9 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.9 | 9.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.9 | 5.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.9 | 2.7 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.9 | 96.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.9 | 5.3 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.9 | 2.6 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.8 | 10.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.8 | 13.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.8 | 3.3 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.8 | 4.1 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.8 | 4.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.8 | 29.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.8 | 0.8 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.8 | 34.9 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.8 | 21.8 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.8 | 3.9 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.8 | 0.8 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.8 | 5.3 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.8 | 2.3 | REACTOME GLYCOSAMINOGLYCAN METABOLISM | Genes involved in Glycosaminoglycan metabolism |
0.7 | 5.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.7 | 1.5 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.7 | 4.3 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.7 | 1.4 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.7 | 2.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.7 | 19.0 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.7 | 19.6 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.7 | 1.4 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.7 | 3.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.7 | 8.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.7 | 51.0 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.7 | 2.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.7 | 14.5 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.6 | 7.0 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.6 | 5.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.6 | 1.9 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.6 | 0.6 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.6 | 5.0 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.6 | 8.1 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.6 | 13.0 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.6 | 0.6 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.6 | 3.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.6 | 7.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.6 | 4.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.6 | 11.4 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.6 | 7.2 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.6 | 5.4 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.6 | 6.5 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.6 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.6 | 9.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.6 | 7.1 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.6 | 23.4 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.6 | 3.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.6 | 6.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.6 | 25.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.6 | 8.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.5 | 6.0 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.5 | 1.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.5 | 1.6 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.5 | 3.7 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.5 | 21.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.5 | 4.1 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.5 | 0.5 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.5 | 2.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.5 | 6.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.5 | 16.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.5 | 6.8 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.5 | 6.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.5 | 9.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.5 | 3.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.5 | 1.0 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.5 | 10.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.5 | 10.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.5 | 3.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.5 | 4.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.5 | 9.0 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.4 | 4.9 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.4 | 8.2 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.4 | 0.9 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.4 | 12.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.4 | 2.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.4 | 3.8 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.4 | 2.9 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.4 | 0.4 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.4 | 6.8 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.4 | 4.0 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.4 | 5.1 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.4 | 5.8 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.4 | 0.7 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.4 | 2.2 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.4 | 3.6 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.4 | 0.7 | REACTOME INSULIN RECEPTOR SIGNALLING CASCADE | Genes involved in Insulin receptor signalling cascade |
0.4 | 5.0 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.4 | 3.9 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 4.9 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.3 | 2.8 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 1.4 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.3 | 6.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 2.0 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.3 | 4.0 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.3 | 3.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.3 | 3.9 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.3 | 0.6 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.3 | 2.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 4.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.3 | 13.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.3 | 0.6 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.3 | 3.3 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.3 | 3.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.3 | 6.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.3 | 0.9 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.3 | 2.3 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.3 | 1.7 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.3 | 2.3 | REACTOME OPSINS | Genes involved in Opsins |
0.3 | 24.2 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.3 | 5.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.3 | 3.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.3 | 1.4 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.3 | 11.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.3 | 1.8 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.3 | 3.0 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.3 | 4.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.2 | 11.6 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.2 | 2.9 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 46.3 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.2 | 4.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 1.9 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 1.4 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.2 | 9.6 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.2 | 2.8 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 1.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 26.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 0.7 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.2 | 0.4 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 2.4 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.2 | 0.2 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.2 | 2.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 4.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 1.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 3.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 1.3 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.2 | 0.9 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.2 | 1.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 0.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 1.9 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.2 | 1.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 0.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.2 | 2.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 13.7 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.2 | 12.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.2 | 0.8 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.2 | 6.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 0.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 0.3 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 0.7 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 1.0 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.1 | 3.0 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 0.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 0.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 0.5 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.1 | 2.6 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 1.5 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 0.5 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 0.8 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 0.4 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 1.5 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.1 | 1.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 1.2 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 0.2 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 2.8 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.1 | 1.8 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 5.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 5.7 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 0.4 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 2.1 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 1.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 0.9 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 1.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.8 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 0.9 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 0.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.6 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
0.0 | 0.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 1.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.0 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.1 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.0 | 0.6 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.0 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 1.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.1 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |